BC Cancer, part of the Provincial Health Services Authority, Technology Development Office, Data Access Committee (PHSA TDO DAC)

Request Access

This DAC controls 2147 datasets

Dataset ID	Description	Technology	Samples
EGAD00000000045	Genomic sequencing and transcriptome shotgun sequencing of a metastatic tumour and its recurrence after drug therapy in a single patient	Illumina Genome Analyzer II	1
EGAD00000000046	RNA-SEQ data from 3 recurrent and 1 ovarian primary Granulosa Cell Tumour samples		4
EGAD00000000047	Signal data for from 3 recurrent and 1 ovarian primary Granulosa Cell Tumour samples		4
EGAD00000000048	Sequencing data from oestrogen-receptor-alpha-positive metastatic lobular breast cancer sample	Illumina Genome Analyzer II	1
EGAD00000000049	RNA-SEQ data from oestrogen-receptor-alpha-positive metastatic lobular breast cancer sample	Illumina Genome Analyzer II	1
EGAD00000000114	Whole transcriptome sequence data from 18 ovarian clear-cell carcinoma samples and one TOV21G ovarian clear-cell carcinoma cell line	Illumina Genome Analyzer II	1
EGAD00001000057	RNA-Seq analysis	Illumina Genome Analyzer II	15
EGAD00001000058	Exome Sequencing analysis	Illumina Genome Analyzer II	21
EGAD00001000113	Mutational landscapes of primary triple negative breast cancers - Exomes	Illumina Genome Analyzer IIx	108
EGAD00001000115	Mutational landscapes of primary triple negative breast cancers - WGS	ABI_SOLID	32
EGAD00001000132	Mutational landscapes of primary triple negative breast cancers - RNA seq	Illumina Genome Analyzer IIx	80
EGAD00001000370	This dataset is compromised of 5 sequencing experiments from a single patient with sporadic and recurring parathyroid carcinoma. The samples include whole genome sequence of the primary tumor, the first recurrent tumor and peripheral blood. Whole transcriptome sequence of the first and second recurrent tumors are also included.	Illumina HiSeq 2000	5
EGAD00001000669	High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to the emergence of treatment-resistant subclones. We sought to measure the degree of genomic diversity within primary, untreated HGSCs to examine the natural state of tumour evolution prior to therapy. We performed exome sequencing, copy number analysis, targeted amplicon deep sequencing and gene expression profiling on 31 spatially and temporally separated HGSC tumour specimens (six patients), including ovarian masses, distant metastases and fallopian tube lesions. We found widespread intratumoural variation in mutation, copy number and gene expression profiles, with key driver alterations in genes present in only a subset of samples (eg PIK3CA, CTNNB1, NF1). On average, only 51.5% of mutations were present in every sample of a given case (range 10.2 to 91.4%), with TP53 as the only somatic mutation consistently present in all samples. Complex segmental aneuploidies, such as whole-genome doubling, were present in a subset of samples from the same individual, with divergent copy number changes segregating independently of point mutation acquisition. Reconstruction of evolutionary histories showed one patient with mixed HGSC and endometrioid histology, with common aetiologic origin in the fallopian tube and subsequent selection of different driver mutations in the histologically distinct samples. In this patient, we observed mixed cell populations in the early fallopian tube lesion, indicating that diversity arises at early stages of tumourigenesis. Our results revealed that HGSCs exhibit highly individual evolutionary trajectories and diverse genomic tapestries prior to therapy, exposing an essential biological characteristic to inform future design of personalized therapeutic solutions and investigation of drug-resistance mechanisms	Illumina Genome Analyzer	25
EGAD00001000692	Files associated with the dataset: HS1626.bam, HS1484.bam, HS1483.bam, HS1482.bam, HS1481.bam, HS1480.bam, HS1479.bam, HS1478.bam, A13805.bam, A13800.bam, A13799.bam, A05253.bam, A05252.bam, A13806.bam	Illumina Genome Analyzer Illumina Genome Analyzer II Illumina HiSeq 2000	12
EGAD00001000702	Complete set of bam files associated with study EGAS00001000622		190
EGAD00001000794	Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare, aggressive cancer affecting children and young women. We identified germline and somatic inactivating mutations in the SWI/SNF chromatin-remodeling gene SMARCA4 in 75% (9/12) of SCCOHT patients in addition to SMARCA4 protein loss in 82% (14/17) of SCCOHT tumors, but in only 0.4% (2/485) of other primary ovarian tumors. These data implicate SMARCA4 in SCCOHT oncogenesis.	Illumina HiSeq 2000	11
EGAD00001000850	Small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is an extremely rare, aggressive cancer affecting children and young women. We identified germline and somatic inactivating mutations in the SWI/SNF chromatin-remodeling gene SMARCA4 in 75% (9/12) of SCCOHT patients in addition to SMARCA4 protein loss in 82% (14/17) of SCCOHT tumors, but in only 0.4% (2/485) of other primary ovarian tumors. These data implicate SMARCA4 in SCCOHT oncogenesis.	Illumina HiSeq 2000	19
EGAD00001000974	High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to emergence of treatment-resistant sub-clones. We sought to measure the degree of genomic diversity within primary, untreated HGSC to examine the natural state of tumor evolution prior to therapy. We performed exome sequencing, copy number analysis, targeted amplicon deep sequencing and gene expression profiling on thirty-one spatially and temporally separated HGSC tumor specimens (six patients) including ovarian masses, distant metastases, and fallopian tube lesions. We found widespread intra-tumoral variation in mutation, copy number, and gene expression profiles, with key driver alterations in genes present in only a subset of samples (e.g. PIK3CA, CTNNB1, NF1). On average, only 51.5% of mutations were present in every sample of a given case (range: 10.2% to 91.4%), with TP53 as the only somatic mutation consistently present in all samples. Complex segmental aneuploidies, such as whole genome doubling, were present in a subset of samples from the same individual, with divergent copy number changes segregating independently of point mutation acquisition. Reconstruction of evolutionary histories showed one patient with mixed HGSC and endometrioid histology with common etiologic origin in the fallopian tube and subsequent selection of different driver mutations in the histologically distinct samples. In this patient, we observed mixed cell populations in the early fallopian tube lesion, indicating diversity arises at early stages of tumorigenesis. Our results reveal that HGSC exhibit highly individual evolutionary trajectories and diverse genomic tapestries prior to therapy, exposing an essential biological characteristic to inform future design of personalized therapeutic solutions and investigation of drug resistance mechanisms.	Illumina HiSeq 2000 Illumina MiSeq	131
EGAD00001000978	Multi-region whole genome sequencing of an high grade serous ovarian carcinoma sample for characterization of genomic intra-tumoural heterogeneity.	Illumina HiSeq 2000	48
EGAD00001001066	Dynamics of genomic clones in breast cancer patient xenografts at single cell resolution	Illumina HiSeq 2000 Illumina MiSeq	188
EGAD00001001073	miRNA-seq Cohort of 140 Formalin Fixed Paraffin Embedded Diffuse Large B-cell Lymphoma Patient Samples		140
EGAD00001001074	miRNA-seq Cohort of 92 Fresh Frozen Diffuse Large B-cell Lymphoma Patient Samples		92
EGAD00001001075	miRNA-seq Cohort of 15 Benign Centroblasts		15
EGAD00001001085	This dataset includes 2 pairs of tumour/normal whole genome sequence data as well as MEN1 gene targeted sequencing of an additional 87 specimens.	Illumina HiSeq 2500 Illumina MiSeq	91
EGAD00001001226	smRNA-Seq assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Canada as part of the International Human Epigenome Consortium.		28
EGAD00001001227	Strand-specific mRNA-Seq assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.		32
EGAD00001001228	Whole genome shotgun sequencing assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.		27
EGAD00001001229	ChIP-Seq (H3K27ac) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001230	ChIP-Seq (H3K27me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001231	ChIP-Seq (H3K36me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001232	ChIP-Seq (H3K4me1) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001233	ChIP-Seq (H3K4me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001234	ChIP-Seq (H3K9me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000;ILLUMINA	48
EGAD00001001235	ChIP-Seq (Input) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.		48
EGAD00001001307	Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001308	Genome and transcriptome sequence data from a primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	MinION PromethION	3
EGAD00001001309	Genome and transcriptome sequence data from an appendix cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001310	Genome and transcriptome sequence data from a peritoneal mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001311	Genome and transcriptome sequence data from a peritoneal mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001312	Fastq data for whole genome bisulfite sequencing assays for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	30
EGAD00001001321	This dataset includes WGS & WTS alignment data generated from 1 ATC tumor, its matched peripheral blood specimen and 3 authenticated ATC cell lines, THJ-16T, THJ-21T and THJ-29T. In addition, it includes WTS data from extra 4 unique anaplastic cell lines, ACT-1, C643, HTh7 and T238.	Illumina HiSeq 2000 Illumina HiSeq 2500	13
EGAD00001001400	Fastq data for whole genome shotgun sequencing assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	27
EGAD00001001401	Fastq data for smRNA-Seq assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000	28
EGAD00001001402	Fastq data for stranded mRNA-Seq assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	32
EGAD00001001403	Fastq data for ChIP-Seq (H3K27ac) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001404	Fastq data for ChIP-Seq (H3K27me3) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001405	Fastq data for ChIP-Seq (H3K36me3) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001406	Fastq data for ChIP-Seq (H3K4me1) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001407	Fastq data for ChIP-Seq (H3K4me3) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001408	Fastq data for ChIP-Seq (H3K9me3) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001409	Fastq data for ChIP-Seq (Input) assays assay for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2000 Illumina HiSeq 2500	48
EGAD00001001417	bam files associated with the study EGAS00001001205		6
EGAD00001001435	Aligned whole genome bisulfite sequencing data for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.		30
EGAD00001001439	Mammary cell samples from donors 28/32/33. Contains 12 MiSeq sequencefiles and 12 alignment files derived from HiSeq runs.	Illumina MiSeq	12
EGAD00001001467	WGS of 8 trios - affected child and both normal parents		24
EGAD00001001618	Sequence data from two medullary thyroid carcinoma patients: WGS datasets generated from tumors and matched normal tissues and RNA-Seq from tumors are included.	Illumina HiSeq 2000 Illumina HiSeq 2500	6
EGAD00001001646	Fastq files corresponding to RNA-Seq dataset for PTPN1 project (EGAS00001000554)	Illumina Genome Analyzer Illumina Genome Analyzer II Illumina HiSeq 2000	10
EGAD00001001655	Genome and transcriptome sequence data from an atypical teratoid rhabdoid tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001656	Genome and transcriptome sequence data from an atypical chronic lymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001657	Genome and transcriptome sequence data from a parotid gland cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001658	Genome and transcriptome sequence data from an odontogenic ghost cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001876	Genome and transcriptome sequence data from a colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study. These data are included in the manuscript entitled, "Response to Angiotensin Blockade with Irbesartan in a Patient with Metastatic Colorectal Cancer".		4
EGAD00001001885	January 2016 update of RNA-Seq data (bams, fastqs) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	17
EGAD00001001957	March 2016 update of Whole genome bisulfite sequencing assay data (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	18
EGAD00001001958	March 2016 update of whole genome shotgun sequencing data (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	17
EGAD00001001959	March 2016 update of smRNA-Seq assays data (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	20
EGAD00001001961	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		4
EGAD00001001962	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001963	Genome and transcriptome sequence data from a non small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001964	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001965	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001001966	Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	3
EGAD00001001967	Genome and transcriptome sequence data from an adenocarcinoma of right lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001968	Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	2
EGAD00001001969	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001001987	March 2016 update of Whole genome bisulfite sequencing assay data (bams) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.		18
EGAD00001002017	Genome and transcriptome sequence data from a breast primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002018	Genome and transcriptome sequence data from a melanoma skin cancer - squamous cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		4
EGAD00001002019	Genome and transcriptome sequence data from a patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002020	Genome and transcriptome sequence data from a metastatic NPC patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002021	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002022	Genome and transcriptome sequence data from a colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002023	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002024	Genome and transcriptome sequence data from an anal rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002025	Genome and transcriptome sequence data from a colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002026	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		4
EGAD00001002027	Genome and transcriptome sequence data from a colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002028	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002029	Genome and transcriptome sequence data from an ovarian granulosa patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002030	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002031	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002032	Genome and transcriptome sequence data from an adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002033	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002034	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002035	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002036	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002037	Genome and transcriptome sequence data from an adrenal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002038	Genome and transcriptome sequence data from a peripheral T-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		5
EGAD00001002039	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002040	Genome and transcriptome sequence data from a squamous cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002041	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002042	Genome and transcriptome sequence data from an endometrial cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002043	Genome and transcriptome sequence data from a recurrent glioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002044	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002045	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002046	Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002047	Genome and transcriptome sequence data from a breast ductal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002048	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002049	Genome and transcriptome sequence data from an adrenal cortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002238	ChIP-Seq (H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3, Input) data for HL60 cell line generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency.	Illumina HiSeq 2000	1
EGAD00001002239	June 2016 data update (bam/fastq for CEMT0062, CEMT0068, CEMT0072, CEMT0086, CEMT0087 ChIP-Seq and RNA-Seq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	10
EGAD00001002531	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002532	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002533	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002534	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002535	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002536	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002537	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002538	Genome and transcriptome sequence data from a uterine sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002539	Genome and transcriptome sequence data from an oligodendroglioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002540	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002541	Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002542	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002543	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002544	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002545	Genome and transcriptome sequence data from a duodenal malignancy patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002546	Genome and transcriptome sequence data from a melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002547	Exome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		4
EGAD00001002548	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002549	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002550	Genome and transcriptome sequence data from a primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002551	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002552	Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002553	Genome and transcriptome sequence data from an unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002554	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002555	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002556	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002557	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002558	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002559	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002560	Genome and transcriptome sequence data from a cervical cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002561	Genome and transcriptome sequence data from a metastatic cervical cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002562	Genome and transcriptome sequence data from an osteogenic sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002563	Genome and transcriptome sequence data from a follicular lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002564	Genome and transcriptome sequence data from an adenocarcinoma of lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002565	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		5
EGAD00001002566	Genome and transcriptome sequence data from a uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002567	Genome and transcriptome sequence data from a rectosigmoid adenocarcinoma (colorectal cancer) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002568	Genome and transcriptome sequence data from a metastatic endometrial cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002569	Genome and transcriptome sequence data from a primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002570	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002571	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002572	Genome and transcriptome sequence data from an infiltrating ductal carcinoma of right breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002573	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002574	Genome and transcriptome sequence data from a ductal carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002575	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002576	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002577	Genome and transcriptome sequence data from an adenocarcinoma of primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002578	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002579	Genome and transcriptome sequence data from a carcinoma of left lower outer quadrant patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002580	Genome and transcriptome sequence data from a right breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002581	Genome and transcriptome sequence data from a metastatic myxofibrosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002582	Genome and transcriptome sequence data from a squamous cell carcinoma of anal canal patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002583	Genome and transcriptome sequence data from a retroperitoneal leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002584	Genome and transcriptome sequence data from a vulvar metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002585	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002586	Genome and transcriptome sequence data from a squamous cell carcinoma of vulva patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002587	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002588	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002589	Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002590	Genome and transcriptome sequence data from an adenomacarcinoma of vulva patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002591	Genome and transcriptome sequence data from a neuroendocrine tumor likely pancreatic origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	MinION	2
EGAD00001002592	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002593	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002594	Genome and transcriptome sequence data from a peritoneal mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002595	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the GE junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002596	Genome and transcriptome sequence data from a porocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002597	Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002598	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002599	Genome and transcriptome sequence data from a medullary thyroid carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002600	Genome and transcriptome sequence data from an adnexal tumor probable of Wolffian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002601	Genome and transcriptome sequence data from an invasive ductal carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002602	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002603	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002604	Genome and transcriptome sequence data from a clear cell carcinoma of ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002605	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002606	Genome and transcriptome sequence data from an adenocarcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002607	Genome and transcriptome sequence data from a pancreatic cancer (likely PNET) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002608	Genome and transcriptome sequence data from a pleomorphic spindle cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002609	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002610	Genome and transcriptome sequence data from an invasive carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002611	Genome and transcriptome sequence data from an adenocarcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002612	Genome and transcriptome sequence data from an esophageal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002613	Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002614	Genome and transcriptome sequence data from a thymic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002615	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002616	Genome and transcriptome sequence data from a superficial pleomorphic liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002617	Genome and transcriptome sequence data from a small cell/neuroendocrine carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002618	Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002619	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002620	Genome and transcriptome sequence data from a myxoid liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002621	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002622	Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002623	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002624	Genome and transcriptome sequence data from a squamous cell carcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002625	Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002626	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002627	Genome and transcriptome sequence data from an adenoid cystic carcinoma of the trachea patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002628	Genome and transcriptome sequence data from a squamous cell carcinoma of anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002629	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002630	Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002631	Genome and transcriptome sequence data from a serous endometrial cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002632	Genome and transcriptome sequence data from a testicular cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002633	Genome and transcriptome sequence data from an endometrial carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002634	Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002635	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002636	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002637	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002638	Genome and transcriptome sequence data from a metastatic prostate cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002639	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002640	Genome and transcriptome sequence data from a clival chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002641	Genome and transcriptome sequence data from a metastatic small cell carcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002642	Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002643	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002644	Genome and transcriptome sequence data from a multifocal hepatocellular carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002645	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002646	Genome and transcriptome sequence data from an epithelioid mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002647	Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002648	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002724	September 2016 data update (bam/fastq/vcf) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	24
EGAD00001002891	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002896	Amplicon sequencing libraries from the study "Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study". These are Illumina amplicon deep sequencing libraries (n = 118) to validate somatic predictions made in the whole genome sequencing libraries. Specifically, there are 72 tumor libraries and 46 normal libraries. Some patients may have multiple amplicon libraries sequenced.	Illumina HiSeq 2000	118
EGAD00001002897	Whole genome sequencing libraries from the study "Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study". These are libraries from 41 patients. Specifically: 15 transformed follicular lymphoma (TFL), 6 early progressers (PFL), and 20 non-early progressers (NPFL). For TFL and PFL patients, trios consisting of diagnostic (T1), transformed/progressed (T2) and a matching normal are available (n = 63 libaries in total). For NPFL patients, a tumor-normal pair are available (n = 40 libraries).		103
EGAD00001002898	Oliocapture sequencing libraries from the study "Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study". These are sequencing libraries from the extension cohort of 277 patients. Specifically, there are 402 tumor libraries and 82 normal libraries.		484
EGAD00001002972	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002973	Genome and transcriptome sequence data from a rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002974	Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002975	Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of unknown primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002976	Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002977	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002978	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002979	Genome and transcriptome sequence data from a GI primary (prev breast cancer) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002980	Genome and transcriptome sequence data from a metastatic fibrolamellar hepatocelluar carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002981	Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002982	Genome and transcriptome sequence data from a metastatic rectosigmoid adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002983	Genome and transcriptome sequence data from a metastatic carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002984	Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002985	Genome and transcriptome sequence data from a adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002986	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002987	Genome and transcriptome sequence data from a metastatic endocervical adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002988	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002989	Genome and transcriptome sequence data from a medullary thyroid cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002990	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002991	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002992	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002993	Genome and transcriptome sequence data from a metastatic carcinoma of primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002994	Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002995	Genome and transcriptome sequence data from a carcinosarcoma of the uterus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002996	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002997	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001002998	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001002999	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003000	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003001	Genome and transcriptome sequence data from a serous carcinoma of fallopian tube patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003002	Genome and transcriptome sequence data from a metastatic adult granulosa cell tumour patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003003	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003004	Genome and transcriptome sequence data from a glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003005	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003006	Genome and transcriptome sequence data from a metastatic medullary thyroid cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003007	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003008	Genome and transcriptome sequence data from a metastatic adenocarcinoma presumably of ovarian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003009	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003010	Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003011	Genome and transcriptome sequence data from a squamous cell carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003012	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003013	Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003014	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003015	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003016	Genome and transcriptome sequence data from a metastatic ductal carcinoma of the breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003017	Genome and transcriptome sequence data from a metastatic large cell neuroendocrine tumour of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003018	Genome and transcriptome sequence data from a metastatic clear cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003019	Genome and transcriptome sequence data from a metastatic uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003020	Genome and transcriptome sequence data from a low grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003021	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003022	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003023	Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003024	Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003025	Genome and transcriptome sequence data from an endometrial adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003026	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003027	Genome and transcriptome sequence data from an anaplastic myxopapillary ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003028	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003029	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003030	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003031	Genome and transcriptome sequence data from a metastatic collecting duct kidney cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003032	Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003033	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003034	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003035	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003036	Genome and transcriptome sequence data from an ovarian adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003037	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003038	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003039	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003040	Genome and transcriptome sequence data from a chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003041	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003042	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003043	Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003044	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003045	Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003046	Genome and transcriptome sequence data from a sigmoid cancer and an ampullary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003047	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003048	Genome and transcriptome sequence data from a metastatic pancreatic neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003049	Genome and transcriptome sequence data from a prostate cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003050	Genome and transcriptome sequence data from a serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003051	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003052	Genome and transcriptome sequence data from a metastatic malignant peripheral nerve sheath tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003053	Genome and transcriptome sequence data from an adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003054	Genome and transcriptome sequence data from a low-grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003055	Genome and transcriptome sequence data from a small bowel carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003056	Genome and transcriptome sequence data from a solitary fibrous tumors (sarcoma) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	2
EGAD00001003057	Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003058	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003059	Genome and transcriptome sequence data from a metastatic mullerian tumor of endometrium patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003060	Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003061	Genome and transcriptome sequence data from an adenocarcinoma of the distal esophagus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003062	Genome and transcriptome sequence data from an extraosseous osteosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003063	Genome and transcriptome sequence data from an atypical bronchial carcinoid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003064	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003065	Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the palate patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003066	Genome and transcriptome sequence data from an appendiceal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003067	Genome and transcriptome sequence data from a metastatic gastroesophageal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003068	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003069	Genome and transcriptome sequence data from a pancreatic neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003070	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003071	Genome and transcriptome sequence data from a pleural mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003072	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003073	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003074	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003075	Genome and transcriptome sequence data from a metastatic colon caner patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003076	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003077	Genome and transcriptome sequence data from a metastatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003078	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003079	Genome and transcriptome sequence data from a presumed metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003080	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003081	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003082	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003083	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003084	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003085	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003086	Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003087	Genome and transcriptome sequence data from a pancreatic neuroendocrine cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003088	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003089	Genome and transcriptome sequence data from a pancreatic neuroendocrine patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003090	Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003091	Genome and transcriptome sequence data from a clear cell carcinoma of ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003122	December 2016 data update (bam/fastq for WGBS on samples CEMT0062, CEMT0068, CEMT0072, CEMT0086, CEMT0087) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	5
EGAD00001003140	We analyzed the spectrum and clinical significance of MYC and BCL2 mutations in 347 DLBCL cases from population-based cohort of BC, Canada.	Illumina MiSeq	347
EGAD00001003148	Microfluidic direct library preparation (DLP) single-cell whole-genome BAM files for near-diploid immortalized lymphoblastoid cell line GM18507.	NextSeq 500	192
EGAD00001003149	Microfluidic direct library preparation (DLP) single-cell whole-genome BAM files for third-passage patient-derived primary triple-negative breast cancer xenograft SA501X3F.	Illumina HiSeq 2500	384
EGAD00001003150	Microfluidic direct library preparation (DLP) single-cell whole-genome BAM files for fourth-passage patient-derived primary triple-negative breast cancer xenograft SA501X4F.	Illumina HiSeq 2500	384
EGAD00001003151	Bulk whole-genome BAM files for 184-hTERT-L2, SA501X3F, and SA501X4F.	Illumina HiSeq 2500	3
EGAD00001003152	Microfluidic direct library preparation (DLP) single-cell whole-genome BAM files for near-diploid immortalized breast epithelial cell line 184-hTERT-L2.	Illumina HiSeq 2500	192
EGAD00001003265	For CCOC cohorts, OvCaRe cases were reviewed, including frozen material, by at least two expert gynecopathologists prior to inclusion in the sequencing cohort who provided the confirmation on final selected cohort. Frozen H&E from Tokyo were also used for evaluation along with representative H&E photos and review done at the Jikei School of Medicine. All CCOC tumours are primary tumour samples. Library construction and sequencing Frozen specimens with >50% tumour cellularity (based on initial slide review) were used for cryosectioning and subsequent nucleic acid extraction. Patient tumour and normal blood samples derived from primary, untreated fresh frozen tumour specimens harvested at diagnosis during standard of care debulking surgery. Germline DNA was provided from peripheral blood buffy coat on all specimens except 13 from Tokyo, where non-cancer frozen tissue was used as a germline source. DNA extraction from both matched normal (blood) and tumour samples (frozen tissue) were performed using the QIAamp Blood and Tissue DNA kit (Qiagen) and quantified using a Qbit fluorometer and reagents (high-sensitivity assay). Three lanes of Illumina HiSeq 2500 v4 chemistry for normal samples and five lanes for tumour samples were obtained. The PCR-free protocol was adopted to eliminate the PCR-induced bias and improve coverage across the genome.	Illumina Genome Analyzer II Illumina HiSeq 2000	70
EGAD00001003266	For ENOC cohorts, OvCaRe cases were reviewed, including frozen material, by at least two expert gynecopathologists prior to inclusion in the sequencing cohort who provided the confirmation on final selected cohort. Frozen H&E from Tokyo were also used for evaluation along with representative H&E photos and review done at the Jikei School of Medicine. For ENOC, DAH985 and DG1288 are recurrent and both were treated with chemotherapy after their first surgery. DAH123 is a untreated sample, metastasis from an primary endometrial tumour. All HGSC, GCT, CCOC and the rest ENOC tumours are primary tumour samples. Library construction and sequencing Frozen specimens with >50% tumour cellularity (based on initial slide review) were used for cryosectioning and subsequent nucleic acid extraction. Patient tumour and normal blood samples derived from primary, untreated fresh frozen tumour specimens harvested at diagnosis during standard of care debulking surgery. Germline DNA was provided from peripheral blood buffy coat on all specimens except 13 from Tokyo, where non-cancer frozen tissue was used as a germline source. DNA extraction from both matched normal (blood) and tumour samples (frozen tissue) were performed using the QIAamp Blood and Tissue DNA kit (Qiagen) and quantified using a Qbit fluorometer and reagents (high-sensitivity assay). Three lanes of Illumina HiSeq 2500 v4 chemistry for normal samples and five lanes for tumour samples were obtained. The PCR-free protocol was adopted to eliminate the PCR-induced bias and improve coverage across the genome.	Illumina HiSeq 2000	58
EGAD00001003267	For GCT cohorts, OvCaRe cases were reviewed, including frozen material, by at least two expert gynecopathologists prior to inclusion in the sequencing cohort who provided the confirmation on final selected cohort. Frozen H&E from Tokyo were also used for evaluation along with representative H&E photos and review done at the Jikei School of Medicine. All GCT tumours are primary tumour samples. Library construction and sequencing Frozen specimens with >50% tumour cellularity (based on initial slide review) were used for cryosectioning and subsequent nucleic acid extraction. Patient tumour and normal blood samples derived from primary, untreated fresh frozen tumour specimens harvested at diagnosis during standard of care debulking surgery. Germline DNA was provided from peripheral blood buffy coat on all specimens except 13 from Tokyo, where non-cancer frozen tissue was used as a germline source. DNA extraction from both matched normal (blood) and tumour samples (frozen tissue) were performed using the QIAamp Blood and Tissue DNA kit (Qiagen) and quantified using a Qbit fluorometer and reagents (high-sensitivity assay). Three lanes of Illumina HiSeq 2500 v4 chemistry for normal samples and five lanes for tumour samples were obtained. The PCR-free protocol was adopted to eliminate the PCR-induced bias and improve coverage across the genome.	Illumina HiSeq 2000	20
EGAD00001003268	HGSC cases in the OvCaRe and CRCHUM Tumour Banks were selected according to the following criteria: (i) were administered platinum taxane based therapy; (ii) relapsed within 12 months (365 days) or had at least longer than 4.5 years (1642.5 days) follow-up data; (iii) had at least 50% tumour content by H&E staining and expert pathology review. All cases were re-reviewed by expert pathologists to confirm the diagnosis of HGSC. Germline BRCA1 and BRCA2 was determined for all patients through hereditary cancer screening programs. The design of cases selection as a discovery cohort was engineered to amplify biological differences by selecting cases from the extremes of the outcome distribution. All HGSC tumours are primary tumour samples. Library construction and sequencing Frozen specimens with >50% tumour cellularity (based on initial slide review) were used for cryosectioning and subsequent nucleic acid extraction. Patient tumour and normal blood samples derived from primary, untreated fresh frozen tumour specimens harvested at diagnosis during standard of care debulking surgery. Germline DNA was provided from peripheral blood buffy coat on all specimens except 13 from Tokyo, where non-cancer frozen tissue was used as a germline source. DNA extraction from both matched normal (blood) and tumour samples (frozen tissue) were performed using the QIAamp Blood and Tissue DNA kit (Qiagen) and quantified using a Qbit fluorometer and reagents (high-sensitivity assay). Three lanes of Illumina HiSeq 2500 v4 chemistry for normal samples and five lanes for tumour samples were obtained. The PCR-free protocol was adopted to eliminate the PCR-induced bias and improve coverage across the genome.	Illumina HiSeq 2000	118
EGAD00001003272	March 2017 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	8
EGAD00001003293	RNA-Seq and WXS from 6 glioblastoma patients	Illumina HiSeq 2500	11
EGAD00001003395	This dataset consists of the exome sequencing data for 30 tumour and germline DNA pairs derived from relapsed/refractory DLBCL.		60
EGAD00001003414	June 2017 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500 NextSeq 500	40
EGAD00001003422	WXS from barcoded cells that are FACS sorted from GBM-719 xenografts, and the germline reference from patient GBM-719. The 4 xenografts are named according to passage (secondary or tertiary) and treatment (vehicle control or temozolomide).	Illumina HiSeq 2500	5
EGAD00001003603	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003604	Genome and transcriptome sequence data from a metastatic gallbladder cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003605	Genome and transcriptome sequence data from a metastatic colonic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003606	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003607	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003608	Genome and transcriptome sequence data from a metastatic small cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003609	Genome and transcriptome sequence data from a metastatic serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003610	Genome and transcriptome sequence data from a mullerian mixed tumor with carcinosarcoma of the ovaries patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003611	Genome and transcriptome sequence data from a metastatic cecal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003612	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003613	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003614	Genome and transcriptome sequence data from a metastatic non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003615	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003616	Genome and transcriptome sequence data from an adenocarcimona of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003617	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003618	Genome and transcriptome sequence data from a mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003619	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003620	Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003621	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003622	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003623	Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003624	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003625	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003626	Genome and transcriptome sequence data from a retroperitoneal mucinous cystic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003627	Genome and transcriptome sequence data from a salivary duct carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003628	Genome and transcriptome sequence data from a metastatic adenocarcinoma of appendiceal origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003629	Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003630	Genome and transcriptome sequence data from a radiation-induced pleomorphic sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003631	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003632	Genome and transcriptome sequence data from a chronic lymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003633	Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003634	Genome and transcriptome sequence data from a solitary fibrous tumors (sarcoma) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003635	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003636	Genome and transcriptome sequence data from a metastatic paraganglioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003637	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003638	Genome and transcriptome sequence data from a metastatic prostate cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003639	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003640	Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003641	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003642	Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003643	Genome and transcriptome sequence data from a metastatic cecal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003644	Genome and transcriptome sequence data from a metastatic spindle cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003645	Genome and transcriptome sequence data from an anaplastic ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003646	Genome and transcriptome sequence data from a squamous cell carcinoma of ge junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003647	Genome and transcriptome sequence data from an anal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003648	Genome and transcriptome sequence data from a glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003649	Genome and transcriptome sequence data from a metastatic colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003650	Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003651	Genome and transcriptome sequence data from a metastatic colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003652	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003653	Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003654	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003655	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003656	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003657	Genome and transcriptome sequence data from an adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003658	Genome and transcriptome sequence data from a primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	2
EGAD00001003659	Genome and transcriptome sequence data from an ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003660	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003661	Genome and transcriptome sequence data from an advanced adenocarcinoma of lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003662	Genome and transcriptome sequence data from a left cavernous sinus invasive skull meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003663	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003664	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003665	Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003666	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003667	Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003668	Genome and transcriptome sequence data from a metastatic rhabdomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003669	Genome and transcriptome sequence data from a metastatic mucinous adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003670	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003671	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003672	Genome and transcriptome sequence data from a metastatic clear cell ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003673	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the ge junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	2
EGAD00001003674	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003675	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003676	Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003677	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003678	Genome and transcriptome sequence data from a thymoma carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003679	Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003680	Genome and transcriptome sequence data from a low grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003681	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003682	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003683	Genome and transcriptome sequence data from a metastatic high grade sarcomatous neoplasm nos patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003684	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003685	Genome and transcriptome sequence data from an osterosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003686	Genome and transcriptome sequence data from a metastatic neuroendocrine tumor arising from small bowel patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003687	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003688	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003689	Genome and transcriptome sequence data from a metastatic epitheloid angiomyelolipoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003690	Transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		1
EGAD00001003691	Genome sequence data from a metastatic squamous cell carcinoma of the oropharynx patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003692	Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumour patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003693	Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003694	Genome and transcriptome sequence data from a pleomorphic sarcomatoid epithelioid carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003695	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003696	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003697	Genome and transcriptome sequence data from a metastatic meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003698	Genome and transcriptome sequence data from a locally advanced right breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003699	Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003700	Genome and transcriptome sequence data from a thymic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003701	Genome and transcriptome sequence data from a metastatic myoepithelial carcinoma of parotid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003702	Genome and transcriptome sequence data from a high grade serous carcinoma of the fallopian tube/ovary/peritoneum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003708	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003709	Genome and transcriptome sequence data from a high-grade serous fallopian tube carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003710	Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003711	Genome and transcriptome sequence data from a bilateral breast lobular cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003712	Genome and transcriptome sequence data from a primary of unknown origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003713	Genome and transcriptome sequence data from a low-grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003714	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003715	Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003716	Genome and transcriptome sequence data from a melanoma of the right buccal mucosa patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003717	Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003718	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003719	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003720	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003721	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003722	Genome and transcriptome sequence data from a primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003723	Genome and transcriptome sequence data from a squamous cell carcinoma of the anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003724	Genome and transcriptome sequence data from a T-cell rich B cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003725	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectosigmoid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001003726	Genome and transcriptome sequence data from a large-cell neuroendocrine lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003727	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003728	Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003729	Genome and transcriptome sequence data from a peripheral T-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003730	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003731	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003732	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003733	Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003734	Genome and transcriptome sequence data from a spindle cell carcinoma of the left parotid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003735	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003736	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003737	Genome and transcriptome sequence data from a sinus adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003738	Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003739	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003740	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003741	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003742	Genome and transcriptome sequence data from an adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003743	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003744	Genome and transcriptome sequence data from a pleomorphic xanthoastrocytoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001003783	Recent studies using next-generation sequencing strategies have described the landscape of genetic alterations in diffuse large B-cell lymphoma (DLBCL). However, little is known about the clinical relevance of recurrent mutations and copy number alterations and their transcriptional footprints. This study examines the frequency, interaction and clinical impact of recurrent genetic aberrations in DLBCL using high-resolution technologies in a large population-based cohort.	Illumina HiSeq 2000 Illumina HiSeq 2500	376
EGAD00001003810	An RNA Seq study of the effects of HDAC inhibitor Quisinostat on six different synovial sarcoma cell lines	NextSeq 500	12
EGAD00001003906	October 2017 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	Illumina HiSeq 2500	28
EGAD00001003908	- Six samples from the DEV cell line: 2 controls, 2 transduced with IL4R WT and 2 transduced with IL4R mutant (I242N) - This DEV cell line is not commercially available and was acquired from a colleague in the Netherlands		6
EGAD00001003913	74 CD49f single-cell methylomes are from cord blood of donor1, and 84 from cord blood of donor2. Samples from donor1 have one sequencing lane, and samples from donor2 have five sequencing lanes. This dataset was generated using Post-Bisulfite Adapter Ligation (PBAL), a bisulfite based whole genome protocol. In total this dataset consists of 494 runs.	Illumina HiSeq 2500	158
EGAD00001003920	WGS sequence data from cell lines BT-54/BT-88/BT-92/BT-142		7
EGAD00001003955	This dataset comprises single-cell RNA sequencing of the human Lin-CD34+38-45RA-90+49f+ phenotype isolated from 2 normal cord donors. Library preparation was performed following a modified CEL-Seq2 protocol.	NextSeq 500	2
EGAD00001003962	January 2018 data update (bam/fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	34
EGAD00001003963	March 2018 cumulative data release (bams,fastqs) for reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium	HiSeq X Ten Illumina HiSeq 2000 Illumina HiSeq 2500 NextSeq 500	193
EGAD00001003984	Each tumor sample was cut into three pieces, yielding two end-pieces for cryovials and a middle portion placed in 10% buffered formalin. End pieces were homogenized manually and with a paddle blender (Stomacher). All paraffin-embedded blocks, including formalin-fixed tumor samples and molecular-fixed fallopian tubes, were sectioned and stained with hematoxylin and eosin prior to expert histopathological review to confirm the presence of high grade serous carcinoma. Homogenized end pieces were then flash frozen and later used for WGS. For all tumor and matched normal (peripheral blood) samples, DNA was extracted with the Qiagen AllPrep DNA/RNA kit (tumor samples from patients 25,26,28-32) or the Qiagen Blood and Tissue Extraction Kit (tumor samples from patients 1-4,7,9-17, and all blood samples). For all tumor and normal samples, DNA extraction was followed by library construction and sequencing using Illumina HiSeq2500 whole genome shotgun v4 chemistry with paired-end 125bp reads.	Illumina HiSeq 2500	89
EGAD00001003985	Each tumor sample was cut into three pieces, yielding two end-pieces for cryovials and a middle portion placed in 10% buffered formalin. End pieces were homogenized manually and with a paddle blender (Stomacher). All paraffin-embedded blocks, including formalin-fixed tumor samples and molecular-fixed fallopian tubes, were sectioned and stained with hematoxylin and eosin prior to expert histopathological review to confirm the presence of high grade serous carcinoma. Homogenized end pieces were then flash frozen, and RNA was extracted using the miRNeasy Mini kit. Nanodrop was used to assess quality (260/280) and quantity. Total RNA samples were also QC checked using the Caliper HT RNA HiSens assay. Samples ranging from 60-255ng RNA were re-arrayed into a 96-well plate. 5'-RACE PCR was carried out as described in "The interface of malignant and immunologic clonal dynamics in high-grade serous ovarian cancer" (Zhang et al.). Briefly, this involved first round and nested PCR with TRB (TCR beta chain) and IGH (immunoglobulin heavy chain) gene-specific primers. The indexed libraries were sequenced on the Illumina HiSeq platform with paired-end 250bp reads using v2 chemistry reagents.	Illumina HiSeq 2500 NextSeq 500	442
EGAD00001003986	A total of 192 positions per patient were deeply sequenced in each corresponding tumor sample (including 4 experimental controls and SNVs predicted to originate at each node of the sample phylogeny, see Zhang et al. for details). Genomic DNA templates were used as starting material to generate PCR products. PCR was set up using Phusion DNA polymerase according to the manufacturer’s specifications. The standard PCR conditions used were an initial denaturation at 98C for 30 seconds, followed by 35 cycles of 98C for 10 seconds, 60C for 15 seconds and 72C for 8 seconds, and a final extension at 72C for 10 minutes. PCR products were cleaned up using PCRClean DX beads. Amplicons were pooled by template for sequencing sample preparation. Sample preparation involved a second round of amplification using Phusion DNA polymerase with 6 PCR cycles, with primers specified in Zhang et al. DNA quality was assessed using the Caliper LabChip GX HighSensitivity Assay and DNA quantity was measured using a Qubit dsDNA HS assay kit on a Qubit fluorometer. The indexed libraries were pooled together and sequenced on the Illumina NextSeq500 platform with paired-end 150bp reads using v2 chemistry reagents.	NextSeq 500	180
EGAD00001004142	146 DNA samples obtained from 73 DLBCL patients (matching tumor and normal) were sequenced with PCR free 1.0 genome shotgun sequencing. All files are in bam format.		146
EGAD00001004221	WGS and RNA-Seq data from a GBM patient PT-AB0029	Illumina HiSeq 2000	-
EGAD00001004222	WGS and RNA-Seq data from a GBM patient PT-AB6372	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001004223	WGS and RNA-Seq data from a GBM patient PT-AH1410	Illumina HiSeq 2000	-
EGAD00001004224	WGS and RNA-Seq data from a GBM patient PT-AK7565	Illumina HiSeq 2500	-
EGAD00001004225	WGS and RNA-Seq data from a GBM patient PT-AL4257	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001004226	Genome sequence data from a GBM patient PT-AR3050	Illumina HiSeq 2500	-
EGAD00001004227	WGS and RNA-Seq data from a GBM patient PT-AR5365	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004228	WGS and RNA-Seq data from a GBM patient PT-BK0248	Illumina HiSeq 2500	-
EGAD00001004229	WGS and RNA-Seq data from a GBM patient PT-BM772	Illumina HiSeq 2000	1
EGAD00001004230	WGS and RNA-Seq data from a GBM patient PT-CA2271	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004231	WGS and RNA-Seq data from a GBM patient PT-CM1209	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001004232	WGS and RNA-Seq data from a GBM patient PT-DF5919	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001004233	WGS and RNA-Seq data from a GBM patient PT-DS9789	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004234	WGS and RNA-Seq data from a GBM patient PT-EV3071	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004235	WGS and RNA-Seq data from a GBM patient PT-FB6711	Illumina HiSeq 2000	1
EGAD00001004236	Genome sequence data from a GBM patient PT-FR7453		-
EGAD00001004237	WGS and RNA-Seq data from a GBM patient PT-GB9186	Illumina HiSeq 2000	-
EGAD00001004238	WGS and RNA-Seq data from a GBM patient PT-GB9483	Illumina HiSeq 2500	-
EGAD00001004239	WGS and RNA-Seq data from a GBM patient PT-GC1519	Illumina HiSeq 2500	1
EGAD00001004240	WGS and RNA-Seq data from a GBM patient PT-GJ3716	Illumina HiSeq 2500	2
EGAD00001004241	WGS and RNA-Seq data from a GBM patient PT-GR2309	Illumina HiSeq 2500	-
EGAD00001004242	WGS and RNA-Seq data from a GBM patient PT-HN6692	Illumina HiSeq 2500	-
EGAD00001004243	WGS and RNA-Seq data from a GBM patient PT-HO0394	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004244	WGS data from a GBM patient PT-HS9105		-
EGAD00001004245	WGS and RNA-Seq data from a GBM patient PT-JB1730	Illumina HiSeq 2000	-
EGAD00001004246	WGS and RNA-Seq data from a GBM patient PT-JE6375	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004247	WGS and RNA-Seq data from a GBM patient PT-JP2405	Illumina HiSeq 2500	-
EGAD00001004248	WGS and RNA-Seq data from a GBM patient PT-JW6420	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004249	WGS and RNA-Seq data from a GBM patient PT-KM5291	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004250	WGS and RNA-Seq data from a GBM patient PT-LC3356	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004251	WGS and RNA-Seq data from a GBM patient PT-LR9369	Illumina HiSeq 2000	-
EGAD00001004252	WGS and RNA-Seq data from a GBM patient PT-LS4891	Illumina HiSeq 2000	-
EGAD00001004253	WGS and RNA-Seq data from a GBM patient PT-MB9777	Illumina HiSeq 2000 Illumina HiSeq 2500	3
EGAD00001004254	WGS and RNA-Seq data from a GBM patient PT-MD9088	Illumina HiSeq 2500	1
EGAD00001004255	WGS and RNA-Seq data from a GBM patient PT-PD6881	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004256	WGS and RNA-Seq data from a GBM patient PT-RD1291	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004257	WGS and RNA-Seq data from a GBM patient PT-RL5404	Illumina HiSeq 2000	1
EGAD00001004258	WGS and RNA-Seq data from a GBM patient PT-RL7940	Illumina HiSeq 2000	-
EGAD00001004259	WGS and RNA-Seq data from a GBM patient PT-RW9277	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004260	WGS and RNA-Seq data from a GBM patient PT-SK0976	Illumina HiSeq 2000 Illumina HiSeq 2500	1
EGAD00001004261	WGS and RNA-Seq data from a GBM patient PT-SO0258	Illumina HiSeq 2000	1
EGAD00001004262	WGS and RNA-Seq data from a GBM patient PT-TM5196	Illumina HiSeq 2500	1
EGAD00001004263	WGS and RNA-Seq data from a GBM patient PT-VO7089	Illumina HiSeq 2000 Illumina HiSeq 2500	-
EGAD00001004264	WGS data from a GBM patient PT-WP9124	Illumina HiSeq 2500	1
EGAD00001004300	June 2018 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	4
EGAD00001004482	Whole genome sequencing and whole exome sequencing of 13 pediatric osteosarcoma patients including 13 primary, 10 metastatic, and 3 relapsed tumors.	Illumina HiSeq 2000 Illumina HiSeq 2500	78
EGAD00001004552	10X genomics chromium single-cell RNA-sequencing of (i) patient derived triple negative breast cancer xenograft (ii) primary tumour and ascites ovarian cancer cell lines at tumour recurrence.	NextSeq 550	3
EGAD00001004553	Direct library preparation+ single-cell DNA-sequencing of (i) patient derived triple negative breast cancer xenograft (ii) primary tumour and ascites ovarian cancer cell lines at tumour recurrence.	Illumina HiSeq 2500	980
EGAD00001004585	None	Illumina HiSeq 2500 NextSeq 500	40
EGAD00001004596	Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004597	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004598	Genome and transcriptome sequence data from a mucinous colloid carcinoma of the pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004599	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004600	Genome and transcriptome sequence data from a non-small cell adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004601	Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004602	Genome and transcriptome sequence data from a metastatic synovial sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004603	Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of the cheek patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004604	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004605	Genome and transcriptome sequence data from a metastatic choroidal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004606	Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	MinION PromethION	2
EGAD00001004607	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004608	Genome and transcriptome sequence data from a clear cell carcinoma of the left ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004609	Genome and transcriptome sequence data from a low grade chondrosarcoma (bronchus) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004610	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004611	Genome and transcriptome sequence data from a follicular lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004612	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004613	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004614	Genome and transcriptome sequence data from a metastatic follicular thyroid carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004615	Genome and transcriptome sequence data from a ganglioglioma of the left temporal lobe patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004616	Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of the cervix patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004617	Genome and transcriptome sequence data from a anorectal gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004618	Genome and transcriptome sequence data from a metastatic mmmt of the endometrium patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004619	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the stomach patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004620	Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004621	Genome and transcriptome sequence data from a metastatic basal cell carcinoma of frontal scalp patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004622	Genome and transcriptome sequence data from a metastatic rectosigmoid cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004623	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004624	Genome and transcriptome sequence data from a double-hit lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004625	Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004626	Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004627	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectosigmoid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004628	Genome and transcriptome sequence data from a osteosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004629	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004630	Genome and transcriptome sequence data from a metastatic basal cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004631	Genome and transcriptome sequence data from a metastatic breast cancer ER+ patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004632	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004633	Genome and transcriptome sequence data from a metastatic renal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004634	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004635	Genome and transcriptome sequence data from a extramedullary spinal ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004636	Genome and transcriptome sequence data from a metastatic endometrioid/mucinous ovarian carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004637	Genome and transcriptome sequence data from a metastatic clear cell carcinoma of gynecological origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004638	Genome and transcriptome sequence data from a high grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004639	Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004640	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004641	Genome and transcriptome sequence data from a metastatic alveolar soft part sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004642	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004643	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004644	Genome and transcriptome sequence data from a metastatic lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004645	Genome and transcriptome sequence data from a metastatic fibrosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004646	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004647	Genome and transcriptome sequence data from a metastatic uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004648	Genome and transcriptome sequence data from a high grade sarcoma of the epithelioid/spindle cell patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004649	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004650	Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004651	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004652	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the stomach patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004653	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004654	Genome and transcriptome sequence data from a breast invasive ductal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004655	Genome and transcriptome sequence data from a locally advanced oropharyngeal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004656	Genome and transcriptome sequence data from a primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004657	Genome and transcriptome sequence data from a metastatic ampullar carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004658	Genome and transcriptome sequence data from a metastatic osteosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004659	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004660	Genome and transcriptome sequence data from a metastatic primitive neuro-ectodermal tumor of the testicle patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004661	Genome and transcriptome sequence data from a metastatic clear cell carcinoma of the ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004662	Genome and transcriptome sequence data from a metastatic leiomyosarcoma of pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004663	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004664	Genome and transcriptome sequence data from a neuroendocrine carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004665	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004666	Genome and transcriptome sequence data from a metastatic pancreatic neck adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004667	Genome and transcriptome sequence data from a metastatic uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004668	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the esophagus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004669	Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004670	Genome and transcriptome sequence data from a metastatic spindle cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004671	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004672	Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004673	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004674	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004675	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004676	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004677	Genome and transcriptome sequence data from a metastatic colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004678	Genome and transcriptome sequence data from a metastatic thymic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004679	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004680	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004681	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004682	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004683	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004684	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the GE junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004685	Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004686	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004687	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004688	Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004689	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004690	Genome and transcriptome sequence data from a angiosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004691	Genome and transcriptome sequence data from a metastatic transverse colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004692	Genome and transcriptome sequence data from a metastatic non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004693	Genome and transcriptome sequence data from a metastatic carcinoma to paraspinal mass with primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004694	Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004695	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	MinION PromethION	2
EGAD00001004696	Genome and transcriptome sequence data from a peripheral T-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004697	Genome and transcriptome sequence data from a low-grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004698	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004699	Genome and transcriptome sequence data from a lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004700	Genome and transcriptome sequence data from a metastatic lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004701	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004702	Genome and transcriptome sequence data from a high grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004703	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004704	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004705	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004706	Genome and transcriptome sequence data from a adenocarcinoma of the liver patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004707	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004708	Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004709	Genome and transcriptome sequence data from a metastatic high-grade adenocarcinoma of the fallopian tubes patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004710	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004711	Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004713	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004714	Genome and transcriptome sequence data from a metastatic non-small cell lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004715	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004716	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004717	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004718	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004719	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1340 samples; filetype=bam	Illumina HiSeq 2500	1340
EGAD00001004720	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 2057 samples; filetype=bam	Illumina HiSeq 2500	2057
EGAD00001004721	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1970 samples; filetype=bam	Illumina HiSeq 2500	1970
EGAD00001004722	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 2091 samples; filetype=bam	Illumina HiSeq 2500	2091
EGAD00001004723	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1267 samples; filetype=bam	Illumina HiSeq 2500	1267
EGAD00001004724	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 230 samples; filetype=bam	Illumina HiSeq 2500	230
EGAD00001004725	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 232 samples; filetype=bam	Illumina HiSeq 2500	232
EGAD00001004726	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 239 samples; filetype=bam	Illumina HiSeq 2500	239
EGAD00001004727	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 692 samples; filetype=bam	Illumina HiSeq 2500	692
EGAD00001004728	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 612 samples; filetype=bam	Illumina HiSeq 2500	612
EGAD00001004729	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1700 samples; filetype=bam	Illumina HiSeq 2500	1700
EGAD00001004730	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 628 samples; filetype=bam	Illumina HiSeq 2500	628
EGAD00001004731	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 596 samples; filetype=bam	Illumina HiSeq 2500	596
EGAD00001004732	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1735 samples; filetype=bam	Illumina HiSeq 2500	1735
EGAD00001004733	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 585 samples; filetype=bam	NextSeq 550	585
EGAD00001004734	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 766 samples; filetype=bam	NextSeq 550	766
EGAD00001004735	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 2055 samples; filetype=bam	Illumina HiSeq 2500	2055
EGAD00001004736	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 620 samples; filetype=bam	Illumina HiSeq 2500	620
EGAD00001004737	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 624 samples; filetype=bam	NextSeq 550	624
EGAD00001004738	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 481 samples; filetype=bam	NextSeq 550	481
EGAD00001004739	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 378 samples; filetype=bam	Illumina HiSeq 2500	378
EGAD00001004740	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 735 samples; filetype=bam	Illumina HiSeq 2500	735
EGAD00001004741	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 718 samples; filetype=bam	Illumina HiSeq 2500	718
EGAD00001004742	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 493 samples; filetype=bam	NextSeq 550	493
EGAD00001004743	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1222 samples; filetype=bam	Illumina HiSeq 2500	1222
EGAD00001004744	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 522 samples; filetype=bam	Illumina HiSeq 2500	522
EGAD00001004745	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 488 samples; filetype=bam	Illumina HiSeq 2500	488
EGAD00001004746	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 509 samples; filetype=bam	NextSeq 550	509
EGAD00001004747	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 604 samples; filetype=bam	NextSeq 550	604
EGAD00001004748	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 626 samples; filetype=bam	NextSeq 550	626
EGAD00001004749	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 635 samples; filetype=bam	Illumina HiSeq 2500	635
EGAD00001004750	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1522 samples; filetype=bam	HiSeq X Five	1522
EGAD00001004751	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 465 samples; filetype=bam	NextSeq 550	465
EGAD00001004752	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 606 samples; filetype=bam	Illumina HiSeq 2500	606
EGAD00001004753	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 615 samples; filetype=bam	NextSeq 550	615
EGAD00001004754	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 636 samples; filetype=bam	NextSeq 550	636
EGAD00001004755	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 968 samples; filetype=bam	HiSeq X Five	968
EGAD00001004756	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 480 samples; filetype=bam	NextSeq 550	480
EGAD00001004757	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 561 samples; filetype=bam	NextSeq 550	561
EGAD00001004758	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 844 samples; filetype=bam	HiSeq X Five	844
EGAD00001004759	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 928 samples; filetype=bam	HiSeq X Five	928
EGAD00001004760	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 635 samples	HiSeq X Five	635
EGAD00001004761	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1072 samples	HiSeq X Five	1072
EGAD00001004762	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1436 samples; filetype=bam	HiSeq X Five	1436
EGAD00001004763	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 589 samples; filetype=bam	HiSeq X Five	589
EGAD00001004764	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 656 samples; filetype=bam	HiSeq X Five	656
EGAD00001004765	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 648 samples; filetype=bam	HiSeq X Five	648
EGAD00001004766	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 375 samples; filetype=bam	HiSeq X Five	375
EGAD00001004767	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 755 samples; filetype=bam	HiSeq X Five	755
EGAD00001004768	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 492 samples; filetype=bam	HiSeq X Five	492
EGAD00001004769	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 531 samples; filetype=bam	HiSeq X Five	531
EGAD00001004770	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 1222 samples; filetype=bam	HiSeq X Five	1063
EGAD00001004771	Transposase-based amplification-free single-cell genome direct library preparation in nanowell chips; 522 samples; filetype=bam	HiSeq X Five Illumina HiSeq 2500	742
EGAD00001004812	40 samples; filetype=bam	Illumina HiSeq 2500	40
EGAD00001004813	48 samples; filetype=bam	Illumina HiSeq 2500	48
EGAD00001004814	50 samples; filetype=bam	Illumina HiSeq 2500	50
EGAD00001004815	45 samples; filetype=bam	Illumina HiSeq 2500	45
EGAD00001004816	61 samples; filetype=bam	Illumina HiSeq 2500	61
EGAD00001004817	68 samples; filetype=bam	Illumina HiSeq 2500	68
EGAD00001004818	71 samples; filetype=bam	Illumina HiSeq 2500	71
EGAD00001004819	48 samples; filetype=bam	Illumina HiSeq 2500	48
EGAD00001004820	52 samples; filetype=bam	Illumina HiSeq 2500	52
EGAD00001004821	60 samples; filetype=bam	Illumina HiSeq 2500	60
EGAD00001004822	55 samples; filetype=bam	Illumina HiSeq 2500	55
EGAD00001004897	Genome and transcriptome sequence data from a locally advanced breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004898	Genome and transcriptome sequence data from a metastatic rectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004899	Genome and transcriptome sequence data from a invasive ductal carcinoma of right breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004900	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004901	Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004902	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004903	Genome and transcriptome sequence data from a squamous cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004904	Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	2
EGAD00001004905	Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004906	Genome and transcriptome sequence data from a diffuse large B-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004907	Genome and transcriptome sequence data from a T-cell prolymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004908	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004909	Genome and transcriptome sequence data from a metastatic serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004910	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004911	Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004912	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004913	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004914	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004915	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004916	Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004917	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004918	Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004919	Genome and transcriptome sequence data from a abdominal sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004920	Genome and transcriptome sequence data from a meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004921	Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004922	Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004923	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	3
EGAD00001004924	Genome and transcriptome sequence data from a metastatic neuroendocrine tumor, lung primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004925	Genome and transcriptome sequence data from a metastatic choroidal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004926	Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004927	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004928	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004929	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004930	Genome and transcriptome sequence data from a metastatic ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004931	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004932	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004933	Genome and transcriptome sequence data from a metastatic sarcomatoid carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001004934	Genome and transcriptome sequence data from a squamous cell carcinoma of the alveolar ridge patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004935	Genome and transcriptome sequence data from a oligometastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004936	Genome and transcriptome sequence data from a metastatic rectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001004950	March 2019 data update for cord blood CD34+CD38-, CMP, GMP, MEP, monocyte, erythroid precursor, B cell and primary AML total blasts reference epigenomes generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency as part of the International Human Epigenome Consortium. This dataset contains data for samples: CEMT0158 CEMT0159 CEMT0160 CEMT0161 CEMT0162 CEMT0163 CEMT0164 CEMT0165 CEMT0166 CEMT0167 CEMT0168 CEMT0169 CEMT0170 CEMT0171 CEMT0172 CEMT0189	HiSeq X Ten Illumina HiSeq 2500	16
EGAD00001004962	Amplicon sequencing of 10 patients		95
EGAD00001004992	H3K27me3 ChIP-Seq of 6 samples and H3K27ac ChIP-Seq of 4 samples with respective input controls	Illumina HiSeq 2500	20
EGAD00001004993	Ribodepletion RNA-Seq of 8 samples and polyA RNA-Seq of 22 samples	Illumina HiSeq 2500	30
EGAD00001004994	WXS of 3 samples	Illumina HiSeq 2500	3
EGAD00001005060	May 2019 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	8
EGAD00001005141	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005142	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005143	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005144	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005145	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005146	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 24 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005147	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005148	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005149	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005150	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 36 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005151	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 36 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005152	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 24 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005153	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 24 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005154	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005155	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005156	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 24 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005157	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 24 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005158	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005159	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005160	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005161	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005162	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005163	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005164	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005165	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 3 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005166	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005167	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005168	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005169	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005170	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005171	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005172	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005173	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005174	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005175	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005176	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005177	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005178	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005179	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005180	Single-cell RNA-sequencing data generated using the 10X genomics chromium platform, comprising patient derived xenograft, cell line, and primary tumour data. This includes different digestion conditions (37C collagenase vs 6C cold protease) and FACS sorting for live, dying, and dead cells. 12 samples; filetype=fastq	Illumina HiSeq 2000	1
EGAD00001005316	Next generation RNA-Sequencing (RNA-seq) is a flexible approach that can be applied to e.g. global quantification of transcript expression, the characterization of RNA structure such as splicing patterns and profiling of expressed mutations. Many RNA-seq protocols require up to microgram levels of total RNA input amounts to generate high quality data, and thus remain impractical for the limited starting material amounts typically obtained from rare cell populations, such as those from early developmental stages or from laser micro-dissected clinical samples. Here, we present an assessment of the contemporary ribosomal RNA depletion-based protocols, and identify those that are suitable for inputs as low as 1-10 ng of intact total RNA and 100-500 ng of partially degraded RNA from formalin-fixed paraffin-embedded tissues.	Illumina HiSeq 2500 Illumina MiSeq	3
EGAD00001005335	August 2019 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	17
EGAD00001005338	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96146A 1195 samples; filetype=bam	HiSeq X Five	3
EGAD00001005340	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96172B 1694 samples; filetype=bam	HiSeq X Five	3
EGAD00001005345	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96226B 1274 samples; filetype=bam	HiSeq X Five	4
EGAD00001005347	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96193B 2410 samples; filetype=bam	HiSeq X Five	3
EGAD00001005348	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96199A 843 samples; filetype=bam	HiSeq X Five	3
EGAD00001005353	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96199B 1170 samples; filetype=bam	HiSeq X Five	3
EGAD00001005354	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96211C 1397 samples; filetype=bam	HiSeq X Five	3
EGAD00001005355	Whole genome sequencing of single cells identifies stochastic aneuploidies, genome replication, states, and clonal repertoires for library A96225C 1034 samples; filetype=bam	HiSeq X Five	2
EGAD00001005419	Diffuse large B-cell lymphoma (DLBCL) is the most common histologic subtype of non-Hodgkin lymphoma and is notorious for its clinical heterogeneity. Patient outcomes can be predicted by cell-of-origin (COO) classification, demonstrating that the underlying transcriptional signature of malignant B-cells informs biological behavior in the context of standard combination chemotherapy regimens. In the current study, we used mass cytometry (CyTOF) to examine tumor phenotypes at the protein level with single cell resolution in a collection of 27 diagnostic DLBCL biopsy specimens from treatment naïve patients. We found that malignant B-cells from each patient occupied unique regions in 37-dimensional phenotypic space with no apparent clustering of samples into discrete subtypes. Interestingly, variable MHC class II expression was found to be the greatest contributor to phenotypic diversity. Within individual tumors, a subset of cases showed multiple phenotypic subpopulations, and in one case we were able to demonstrate direct correspondence between protein-level phenotypic subsets and DNA mutation-defined subclones. In summary, CyTOF analysis can resolve both inter- and intra-tumoral heterogeneity among primary samples, and reveals that each case of DLBCL is unique and may be comprised of multiple, genetically distinct subclones.		17
EGAD00001005739	Single-cell gene expression was profiled for 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes (2 replicates were performed for RLN-1). Library preparation was performed with the 10x Chromium platform (3' version 2 assay). Sequencing was performed on an Illumina NextSeq. The BAM files were generated from the raw sequencing data using Cell Ranger (v2.1.0) mkfastq and count commands.	Illumina HiSeq 2500	28
EGAD00001005763	Genome and transcriptome sequence data from a metastatic pancreatic neuroendocrine patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study	PromethION	3
EGAD00001005769	Interstitial deletion of the long arm of chromosome 5 (del(5q)) is the commonest structural genomic variant in myelodysplastic syndromes (MDS). Lenalidomide (LEN) is the treatment of choice for patients with del(5q) MDS, but half of the responding patients become resistant within two years. TP53 mutations are detected in ~20% of patients who become resistant to LEN. Our data show that patients who become resistant to LEN harbor either TP53 or RUNX1 mutations or loss of RUNX1 expression. Here we show that LEN-induced degradation of IKZF1 permits a RUNX1/GATA2 complex to drive megakaryocytic differentiation and consequent del(5q) MDS progenitor cell death via CRBN-mediated CSNK1A1 degradation. Overexpression of GATA2 is able to restore LEN sensitivity in the context of RUNX1 or TP53 mutations by enhancing LEN-induced megakaryocytic differentiation. Screening for TP53 and RUNX1 mutations or downregulation should identify patients resistant to LEN, and strategies to activate GATA2 may resensitize del(5q) MDS cells to LEN.		16
EGAD00001005780	Whole-exome sequencing for 95 PMBCL cases (including 21 with matching normal DNA) was performed using a targeted capture approach with the SureSelect Human All Exon V6+UTR bait (Agilent Technologies) followed by massively parallel sequencing of enriched fragments on the HiSeq2500 platform (Illumina). Five libraries were pooled per lane and a 125bp paired-end mode was used. Tumor and normal DNA samples were sequenced to an average of 115X (SD 24X). All reads were aligned to the human reference genome (hg19) using bwa-mem version 0.7.5a29 with optical and PCR duplicates removed using the Picard tool.		116
EGAD00001005823	Genome and transcriptome sequence data from a breast ductal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005824	Genome and transcriptome sequence data from an uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005825	Genome and transcriptome sequence data from a metastatic rectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005826	Genome and transcriptome sequence data from a colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005827	Genome and transcriptome sequence data from a primary unknown- upper GI or pulmonary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005828	Genome and transcriptome sequence data from a metastatic choroidal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005829	Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005830	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005831	Genome and transcriptome sequence data from a poorly differentiated adenocarcinoma more consistent with metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005832	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005833	Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005834	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005835	Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of the esophagus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005836	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005837	Genome and transcriptome sequence data from a metastatic adenocarcinoma of unknown primary (upper GI?) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005838	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005839	Genome and transcriptome sequence data from a metastatic choroid melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005840	Genome and transcriptome sequence data from a carcinoma primary unknown origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005841	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005842	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005843	Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005844	Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005845	Genome and transcriptome sequence data from a metastatic unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005846	Genome and transcriptome sequence data from a cavernous sinus meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005847	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005848	Genome and transcriptome sequence data from a chondrosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005849	Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005850	Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		3
EGAD00001005851	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005852	Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005853	Genome and transcriptome sequence data from a lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005854	Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005855	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005856	Genome and transcriptome sequence data from a cervical adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005857	Genome and transcriptome sequence data from a sex-cord stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005858	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005859	Genome and transcriptome sequence data from an endometrioid ovary carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005860	Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005861	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005862	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005863	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005864	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005865	Genome and transcriptome sequence data from a tongue squamous cell carcinoma (head and neck) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005866	Genome and transcriptome sequence data from a neuroendocrine tumor (GIC) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005867	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005868	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005869	Genome and transcriptome sequence data from a transformed diffuse large B cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005870	Genome and transcriptome sequence data from an osteosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005871	Genome and transcriptome sequence data from a chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005875	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005876	Genome and transcriptome sequence data from a colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005877	Genome and transcriptome sequence data from a malignant epithelial mesothelioma (THR) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005878	Genome and transcriptome sequence data from a melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005879	Genome and transcriptome sequence data from an ovarian cystadenocarcinoma low grade patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005880	Genome and transcriptome sequence data from a lung adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005881	Genome and transcriptome sequence data from a colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005882	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005883	Genome and transcriptome sequence data from a malignant choroid melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005884	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005885	Genome and transcriptome sequence data from a large intestine-colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005886	Genome and transcriptome sequence data from a colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005887	Genome and transcriptome sequence data from a parotid gland adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005888	Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005889	Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005890	Genome and transcriptome sequence data from a melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005891	Genome and transcriptome sequence data from a thyroid hurthle cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005892	Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005893	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005894	Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005895	Genome and transcriptome sequence data from a cecum adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005896	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005897	Genome and transcriptome sequence data from a metastatic adrenocortical cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005898	Genome and transcriptome sequence data from a malignant peripheral nerve sheath tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005899	Genome and transcriptome sequence data from an endometrial stromal sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005900	Genome and transcriptome sequence data from a hemangioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005901	Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005902	Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005903	Genome and transcriptome sequence data from a metastatic gallbladder adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005904	Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005905	Genome and transcriptome sequence data from an adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005906	Genome and transcriptome sequence data from a metastatic clear cell carcinoma of the ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005907	Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005908	Genome and transcriptome sequence data from a squamous cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005909	Genome and transcriptome sequence data from an alveolar soft part sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005910	Genome and transcriptome sequence data from a gastroesophageal junction adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005911	Genome and transcriptome sequence data from a colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005912	Genome and transcriptome sequence data from an unknown tissue unknown histology patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001005913	Genome and transcriptome sequence data from an osteosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001006066	Maps of H3K27ac from normal 2nd- and 3rd-trimester cytotrophoblasts, preterm severe preeclampsia cytotrophoblasts, and 2nd-trimester amnion. Maps of H3K27me3, H3K27me3, H3K36me3, and H3K4me1 from 2nd- and 3rd-trimester cytotrophoblast. Maps of H3K9me3 from 2nd- and 3rd-trimester cytotrophoblast, smooth chorion, and basal plate. RNA-seq from 2nd- and 3rd-trimester cytotrophoblasts.	Illumina HiSeq 2000 Illumina HiSeq 2500	32
EGAD00001006087	18 DLBCL genomes		18
EGAD00001006142	None	Illumina HiSeq 2000	9
EGAD00001006143	None	Illumina HiSeq 2000	29
EGAD00001006159	Tumor and normal exomes for 51 MCL patients and tumor and normal genomes for 34 MCL patients.		170
EGAD00001006220	February 2020 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	28
EGAD00001006221	This dataset contains merged data from the 22 Hodgkin lymphoma and 5 reactive lymph node samples, including count data and cell cluster assignments.		28
EGAD00001006268	RNAseq BAM files for Coding and non-coding mantle cell lymphoma driver mutations		102
EGAD00001006280	Endometrial carcinoma, the most common gynecologic cancer, develops from endometrial epithelium which is composed of secretory and ciliated cells. Pathologic classification is unreliable and there is a need for prognostic tools. We used single cell sequencing to study organoid model systems derived from normal endometrial endometrium to discover novel markers specific for endometrial ciliated or secretory cells. We performed single cell sequencing on endometrial and ovarian tumours, and on organoids both treated with DBZ and normal and found both secretory-like and ciliated-like tumour cells.	NextSeq 550	18
EGAD00001006328	Tumor and matching normal exomes for 28 GZL cases (n=56) and targeted capture sequencing for 42 GZL cases with 3 matching normals and 2 pooled normals (n=47)		103
EGAD00001006383	August 2020 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	HiSeq X Ten Illumina HiSeq 2500	4
EGAD00001006460	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0006_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006461	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0080_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006462	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0080_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006463	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0141_004 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006464	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0142_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006465	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0142_003 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006466	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0146_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006467	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0149_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006468	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0149_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006469	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0150_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006470	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0150_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006471	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0152_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006472	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0152_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006473	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0163_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006474	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0163_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006475	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0172_001 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006476	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0172_002 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006477	Transcriptome profiling by high-throughput sequencing for single cells for library TENX062 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006478	Transcriptome profiling by high-throughput sequencing for single cells for library SCRNA10X_SA_CHIP0063_000 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006479	Transcriptome profiling by high-throughput sequencing for single cells for library TENX064 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006480	Transcriptome profiling by high-throughput sequencing for single cells for library TENX065 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006481	Transcriptome profiling by high-throughput sequencing for single cells for library TENX066 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006482	Transcriptome profiling by high-throughput sequencing for single cells for library TENX068 1 samples; filetype=fastq	Illumina HiSeq 2500	1
EGAD00001006483	Transcriptome profiling by high-throughput sequencing for single cells for library TENX069 1 samples; filetype=fastq	NextSeq 550	1
EGAD00001006537	None	NextSeq 500	12
EGAD00001006627	Fastq files for single cell RNA sequencing of cells from ovarian cancer tumor and ascites (10X chromium 5' v1.1 libraries). Multiple cases are pooled in each sequencing library.	Illumina HiSeq 4000	2
EGAD00001006701	As more clinically-relevant genomic features of myeloid malignancies are revealed, it has become clear that targeted clinical genetic testing is inadequate for risk stratification. Here, we developed and validated a clinical transcriptome-based assay for stratification of acute myeloid leukemia (AML). Comparison of RNA-Seq to whole genome and exome sequencing revealed that as a standalone assay, RNA-Seq offered the greatest diagnostic return, enabling identification of expressed gene fusions, single nucleotide and short insertion/deletion variants, and whole-transcriptome expression information. Expression data were used to develop a novel risk score which, when combined with molecular risk guidelines, allowed for the re-stratification of 22.1 to 25.3% of AML patients from three independent cohorts into correct risk groups. Within the adverse-risk subgroup, we identified a subset of patients characterized by dysregulated integrin signaling and RUNX1 or TP53 mutation. We show that these patients may benefit from therapy with inhibitors of focal adhesion kinase (PTK2), demonstrating additional utility of transcriptome-based testing for therapy selection in myeloid malignancy.		275
EGAD00001006939	Whole genome sequencing for single cells for library A95629A 1023 cells; filetype=bam	HiSeq X Five	5
EGAD00001006940	Whole genome sequencing for single cells for library A95654B 1740 cells; filetype=bam	HiSeq X Five	5
EGAD00001006941	Whole genome sequencing for single cells for library A95673A 1446 cells; filetype=bam	NextSeq 550	9
EGAD00001006942	Whole genome sequencing for single cells for library A95703B 1267 cells; filetype=bam	HiSeq X Five	5
EGAD00001006943	Whole genome sequencing for single cells for library A95728A 876 cells; filetype=bam	HiSeq X Five	5
EGAD00001006944	Whole genome sequencing for single cells for library A96192B 1304 cells; filetype=bam	HiSeq X Five	5
EGAD00001006945	Whole genome sequencing for single cells for library A96217B 1616 cells; filetype=bam	HiSeq X Five	6
EGAD00001006946	Whole genome sequencing for single cells for library A96219B 1743 cells; filetype=bam	HiSeq X Five	7
EGAD00001006947	Whole genome sequencing for single cells for library A98269B 1609 cells; filetype=bam	HiSeq X Five	7
EGAD00001006990	JAGuaR outputs from RNA-seq of 35 pancreatic neuroendocrine neoplasms.	Illumina HiSeq 2500	35
EGAD00001006991	STAR outputs from RNA-seq of 84 pancreatic neuroendocrine neoplasms, 10 normal islet samples and 4 cell line samples.	Illumina HiSeq 2500	98
EGAD00001006992	BWA outputs from whole-exome sequencing of 35 pancreatic neuroendocrine neoplasms.	Illumina HiSeq 2500	35
EGAD00001007006	Tumor exomes for 15 DLBCL samples with PMBL GE signature, with 6 matching normal exomes and 1 pooled normal exome.		22
EGAD00001007086	Whole genome sequencing for single cells for library A108757B 1644 cells; filetype=bam	HiSeq X Five	5
EGAD00001007087	Whole genome sequencing for single cells for library A98299B 991 cells; filetype=bam	HiSeq X Five	5
EGAD00001007088	Whole genome sequencing for single cells for library A108759B 1134 cells; filetype=bam	HiSeq X Five	5
EGAD00001007089	Whole genome sequencing for single cells for library A108768B 1126 cells; filetype=bam	HiSeq X Five	5
EGAD00001007090	Whole genome sequencing for single cells for library A108837A 1435 cells; filetype=bam	HiSeq X Five	5
EGAD00001007091	Whole genome sequencing for single cells for library A108846A 1670 cells; filetype=bam	HiSeq X Five	5
EGAD00001007092	Whole genome sequencing for single cells for library A108846B 1636 cells; filetype=bam	HiSeq X Five	5
EGAD00001007093	Whole genome sequencing for single cells for library A108879A 1567 cells; filetype=bam	HiSeq X Five	5
EGAD00001007094	Whole genome sequencing for single cells for library A110632A 1151 cells; filetype=bam	HiSeq X Five	5
EGAD00001007095	Whole genome sequencing for single cells for library A110632B 892 cells; filetype=bam	HiSeq X Five	5
EGAD00001007096	Whole genome sequencing for single cells for library A118833A 919 cells; filetype=bam	HiSeq X Five	5
EGAD00001007097	Whole genome sequencing for single cells for library A118833B 1147 cells; filetype=bam	HiSeq X Five	5
EGAD00001007098	Whole genome sequencing for single cells for library A118845B 1209 cells; filetype=bam	HiSeq X Five	5
EGAD00001007099	Whole genome sequencing for single cells for library A118869A 1165 cells; filetype=bam	HiSeq X Five	5
EGAD00001007100	Whole genome sequencing for single cells for library A118869B 1124 cells; filetype=bam	HiSeq X Five	5
EGAD00001007101	Whole genome sequencing for single cells for library A73044B 2085 cells; filetype=bam	Illumina HiSeq 2500	5
EGAD00001007102	Whole genome sequencing for single cells for library A73047D 2091 cells; filetype=bam	Illumina HiSeq 2500	5
EGAD00001007103	Whole genome sequencing for single cells for library A95626A 1040 cells; filetype=bam	HiSeq X Five	5
EGAD00001007104	Whole genome sequencing for single cells for library A95633B 2259 cells; filetype=bam	NextSeq 550	7
EGAD00001007105	Whole genome sequencing for single cells for library A95634B 1335 cells; filetype=bam	HiSeq X Five	5
EGAD00001007106	Whole genome sequencing for single cells for library A95646A 1071 cells; filetype=bam	HiSeq X Five	5
EGAD00001007107	Whole genome sequencing for single cells for library A95653B 1342 cells; filetype=bam	HiSeq X Five	5
EGAD00001007108	Whole genome sequencing for single cells for library A95663B 1364 cells; filetype=bam	HiSeq X Five	7
EGAD00001007109	Whole genome sequencing for single cells for library A95675A 668 cells; filetype=bam	HiSeq X Five	5
EGAD00001007110	Whole genome sequencing for single cells for library A95731B 1307 cells; filetype=bam	HiSeq X Five	5
EGAD00001007111	Whole genome sequencing for single cells for library A96115A 1635 cells; filetype=bam	HiSeq X Five	7
EGAD00001007112	Whole genome sequencing for single cells for library A96115B 1201 cells; filetype=bam	HiSeq X Five	5
EGAD00001007113	Whole genome sequencing for single cells for library A96118A 1193 cells; filetype=bam	HiSeq X Five	5
EGAD00001007114	Whole genome sequencing for single cells for library A96130B 1267 cells; filetype=bam	HiSeq X Five	5
EGAD00001007115	Whole genome sequencing for single cells for library A96178A 788 cells; filetype=bam	HiSeq X Five	5
EGAD00001007116	Whole genome sequencing for single cells for library A96178B 846 cells; filetype=bam	HiSeq X Five	5
EGAD00001007117	Whole genome sequencing for single cells for library A96181C 1216 cells; filetype=bam	HiSeq X Five	5
EGAD00001007118	Whole genome sequencing for single cells for library A96193B 2410 cells; filetype=bam	HiSeq X Five	4
EGAD00001007119	Whole genome sequencing for single cells for library A96225B 959 cells; filetype=bam	HiSeq X Five	4
EGAD00001007120	Whole genome sequencing for single cells for library A96225C 1034 cells; filetype=bam	HiSeq X Five	4
EGAD00001007121	Whole genome sequencing for single cells for library A96240A 1493 cells; filetype=bam	HiSeq X Five	5
EGAD00001007122	Whole genome sequencing for single cells for library A96240B 1683 cells; filetype=bam	HiSeq X Five	5
EGAD00001007123	Whole genome sequencing for single cells for library A98172A 898 cells; filetype=bam	HiSeq X Five	5
EGAD00001007124	Whole genome sequencing for single cells for library A98256A 1372 cells; filetype=bam	HiSeq X Five	5
EGAD00001007125	Whole genome sequencing for single cells for library A98256B 1437 cells; filetype=bam	HiSeq X Five	5
EGAD00001007126	Whole genome sequencing for single cells for library A98257B 1286 cells; filetype=bam	HiSeq X Five	5
EGAD00001007127	Whole genome sequencing for single cells for library A98258B 1357 cells; filetype=bam	HiSeq X Five	5
EGAD00001007128	Whole genome sequencing for single cells for library A98274B 1295 cells; filetype=bam	HiSeq X Five	5
EGAD00001007129	Whole genome sequencing for single cells for library A98282A 1198 cells; filetype=bam	HiSeq X Five	5
EGAD00001007130	Whole genome sequencing for single cells for library A98283A 1137 cells; filetype=bam	HiSeq X Five	5
EGAD00001007131	Whole genome sequencing for single cells for library A98285A 1422 cells; filetype=bam	HiSeq X Five	5
EGAD00001007132	Whole genome sequencing for single cells for library A98295B 1381 cells; filetype=bam	HiSeq X Five	5
EGAD00001007306	Whole genome sequencing for single cells for library A95646B 507 cells; filetype=bam	HiSeq X Five	5
EGAD00001007529	November 2020 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	unspecified	10
EGAD00001007592	Whole genome sequencing for single cells for library A108732A 1139 cells; filetype=bam	HiSeq X Five	7
EGAD00001007593	Whole genome sequencing for single cells for library A108735A 714 cells; filetype=bam	NextSeq 550	5
EGAD00001007594	Whole genome sequencing for single cells for library A108833B 866 cells; filetype=bam	HiSeq X Five	7
EGAD00001007595	Whole genome sequencing for single cells for library A108842A 1477 cells; filetype=bam	HiSeq X Five	5
EGAD00001007596	Whole genome sequencing for single cells for library A108851B 1681 cells; filetype=bam	HiSeq X Five	5
EGAD00001007597	Whole genome sequencing for single cells for library A108863A 1301 cells; filetype=bam	HiSeq X Five	5
EGAD00001007598	Whole genome sequencing for single cells for library A108870A 1795 cells; filetype=bam	HiSeq X Five	5
EGAD00001007599	Whole genome sequencing for single cells for library A110618A 1184 cells; filetype=bam	HiSeq X Five	5
EGAD00001007600	Whole genome sequencing for single cells for library A110618B 1047 cells; filetype=bam	HiSeq X Five	5
EGAD00001007601	Whole genome sequencing for single cells for library A110621A 1137 cells; filetype=bam	HiSeq X Five	5
EGAD00001007602	Whole genome sequencing for single cells for library A110673A 1089 cells; filetype=bam	HiSeq X Five	5
EGAD00001007603	Whole genome sequencing for single cells for library A110673B 1153 cells; filetype=bam	HiSeq X Five	5
EGAD00001007604	Whole genome sequencing for single cells for library A118830A 912 cells; filetype=bam	HiSeq X Five	5
EGAD00001007605	Whole genome sequencing for single cells for library A118862A 1070 cells; filetype=bam	HiSeq X Five	5
EGAD00001007606	Whole genome sequencing for single cells for library A118862B 1152 cells; filetype=bam	HiSeq X Five	5
EGAD00001007607	Whole genome sequencing for single cells for library A95623A 1897 cells; filetype=bam	HiSeq X Five	5
EGAD00001007608	Whole genome sequencing for single cells for library A95623B 1363 cells; filetype=bam	HiSeq X Five	5
EGAD00001007609	Whole genome sequencing for single cells for library A95668B 1905 cells; filetype=bam	HiSeq X Five	5
EGAD00001007610	Whole genome sequencing for single cells for library A95697B 1233 cells; filetype=bam	HiSeq X Five	20
EGAD00001007611	Whole genome sequencing for single cells for library A95700A 1172 cells; filetype=bam	HiSeq X Five	5
EGAD00001007612	Whole genome sequencing for single cells for library A95703A 740 cells; filetype=bam	NextSeq 550	5
EGAD00001007613	Whole genome sequencing for single cells for library A95720A 1467 cells; filetype=bam	HiSeq X Five	5
EGAD00001007614	Whole genome sequencing for single cells for library A95730A 739 cells; filetype=bam	HiSeq X Five	5
EGAD00001007615	Whole genome sequencing for single cells for library A96114A 798 cells; filetype=bam	NextSeq 550	5
EGAD00001007616	Whole genome sequencing for single cells for library A96124B 1241 cells; filetype=bam	HiSeq X Five	5
EGAD00001007617	Whole genome sequencing for single cells for library A96155C 1316 cells; filetype=bam	HiSeq X Five	5
EGAD00001007618	Whole genome sequencing for single cells for library A96162A 1505 cells; filetype=bam	HiSeq X Five	5
EGAD00001007619	Whole genome sequencing for single cells for library A96183B 1191 cells; filetype=bam	HiSeq X Five	5
EGAD00001007620	Whole genome sequencing for single cells for library A96190A 1833 cells; filetype=bam	HiSeq X Five	5
EGAD00001007621	Whole genome sequencing for single cells for library A96226B 1274 cells; filetype=bam	HiSeq X Five	7
EGAD00001007622	Whole genome sequencing for single cells for library A96233A 637 cells; filetype=bam	HiSeq X Five	5
EGAD00001007623	Whole genome sequencing for single cells for library A96233B 1601 cells; filetype=bam	HiSeq X Five	5
EGAD00001007624	Whole genome sequencing for single cells for library A98168A 1294 cells; filetype=bam	HiSeq X Five	5
EGAD00001007625	Whole genome sequencing for single cells for library A98168B 1290 cells; filetype=bam	HiSeq X Five	5
EGAD00001007626	Whole genome sequencing for single cells for library A98234A 1240 cells; filetype=bam	HiSeq X Five	5
EGAD00001007627	Whole genome sequencing for single cells for library A98234B 1600 cells; filetype=bam	HiSeq X Five	5
EGAD00001007628	Whole genome sequencing for single cells for library A98244A 1271 cells; filetype=bam	HiSeq X Five	7
EGAD00001007629	Whole genome sequencing for single cells for library A98253A 1250 cells; filetype=bam	HiSeq X Five	5
EGAD00001007630	Whole genome sequencing for single cells for library A98253B 1388 cells; filetype=bam	HiSeq X Five	5
EGAD00001007631	Whole genome sequencing for single cells for library A98254A 1490 cells; filetype=bam	HiSeq X Five	7
EGAD00001007632	Whole genome sequencing for single cells for library A98255B 1394 cells; filetype=bam	HiSeq X Five	5
EGAD00001007633	Whole genome sequencing for single cells for library A98271A 1190 cells; filetype=bam	HiSeq X Five	5
EGAD00001007634	Whole genome sequencing for single cells for library A98289A 1066 cells; filetype=bam	HiSeq X Five	5
EGAD00001007635	Whole genome sequencing for single cells for library A98290B 869 cells; filetype=bam	HiSeq X Five	5
EGAD00001007636	Whole genome sequencing for single cells for library A98304A 1560 cells; filetype=bam	HiSeq X Five	7
EGAD00001007637	Whole genome sequencing for single cells for library A98305A 986 cells; filetype=bam	HiSeq X Five	5
EGAD00001007640	Whole genome sequencing for single cells for library A96120A 1143 cells; filetype=bam	HiSeq X Five	11
EGAD00001007641	Whole genome sequencing for single cells for library A98172B 941 cells; filetype=bam	HiSeq X Five	5
EGAD00001007691	Follicular lymphoma (FL) is an indolent cancer of mature B-cells but carries increased risk of transformation to a more aggressive histology over time. We present here comprehensive profiling both tumor and immune compartments in 6 diagnostic FL biopsies by single-cell RNA sequencing. This confirmed results from 155 FL tumors characterized by mass cytometry (CyTOF) which revealed two distinct evolutionary trajectories with disparate risk of transformation and alternate biologies.		6
EGAD00001007756	OV2295-052021 dataset	Illumina HiSeq 2000	1
EGAD00001007812	We analyzed 34 AGCTs (19 primary and 15 recurrent) and the KGN cell line by RNA-Seq. Our cohort comprised of 3 AGCTs WT for FOXL2, 28 heterozygous and 3 homo/hemizygous for the pathogenic variant. Fresh-frozen AGCTs were selected from OVCARE’s Gynecological Tissue Bank in Vancouver, Canada for bulk RNA-seq. RNA was extracted from frozen tissue and sections adjacent to the scrolls submitted for RNA-seq were stained with hematoxylin and eosin (H&E) to evaluate tumour cell purity. Cases with >80% tumour cell purity were selected for sequencing with the majority of cases (29 of 34 patients) containing >90% tumour cells. Ribodepleted RNA libraries were constructed and paired-end sequencing (125 base pair reads) was performed.	Illumina HiSeq 2500	35
EGAD00001007919	February 2021 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	unspecified	5
EGAD00001007920	This paper describes the work by Akbari V,. et al. on detection of allele specific methylation using oxford nanopore sequencing data. They have developed set of tools, SNVoter and NanoMethPhase, and workflow which enable the detection of allele specific methylation even in samples with sparse coverage of nanopore sequencing data.	PromethION	1
EGAD00001007935	Whole-exome sequencing (~250X coverage) of primary GBM tumours and matched patient-derived organoids and normal blood. Samples from two spatially distinct regions of seven tumours from five patients (five primary, two recurrent).	Illumina HiSeq 2500	29
EGAD00001007936	Single-cell RNA-seq of primary GBM tumours and matched patient-derived organoids and gliomasphere lines. Obtained using the 10X Genomics single-cell 3' expression solution (v2 chemistry). Primary samples and PDOs from 12 tumours from 10 patients (10 primary, two recurrent), and gliomasphere lines from a subset of five tumours. Samples were obtained from two spatially distinct regions of each tumour.	Illumina HiSeq 2500	99
EGAD00001007937	Single-cell whole-genome sequencing of primary GBM tumours and matched patient-derived organoids. Obtained using the 10X Genomics single-cell CNV solution. Samples from two spatially distinct regions of five tumours from three patients (three primary, two recurrent).	HiSeq X Ten	16
EGAD00001008012	Genome and transcriptome sequence data from a poorly differentiated chordoma of C1-C2 spine patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001008013	Genome and transcriptome sequence data from an unspecified tissue chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study		2
EGAD00001008100	May 2021 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	unspecified	17
EGAD00001008101	August 2021 data update (fastq) for reference epigenomes generated at Centre for Epigenome Mapping Technologies (Canadian Epigenetics, Environment and Health Research Consortium), Genome Sciences Center, B.C. Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.	unspecified	13
EGAD00001008218	Whole genome sequencing for single cells for library A96228B 1125 samples; filetype=bam	HiSeq X Five	6
EGAD00001008219	Whole genome sequencing for single cells for library A90679 1034 samples; filetype=bam	Illumina HiSeq 2500	4
EGAD00001008220	Whole genome sequencing for single cells for library A95618A 876 samples; filetype=bam	HiSeq X Five	9
EGAD00001008221	Whole genome sequencing for single cells for library A95628B 1335 samples; filetype=bam	HiSeq X Five	5
EGAD00001008222	Whole genome sequencing for single cells for library A95632D 644 samples; filetype=bam	Illumina HiSeq 2500	5
EGAD00001008223	Whole genome sequencing for single cells for library A95635B 593 samples; filetype=bam	Illumina HiSeq 2500	4
EGAD00001008224	Whole genome sequencing for single cells for library A95635D 367 samples; filetype=bam	Illumina HiSeq 2500	5
EGAD00001008225	Whole genome sequencing for single cells for library A95654A 901 samples; filetype=bam	HiSeq X Five	5
EGAD00001008226	Whole genome sequencing for single cells for library A95662A 637 samples; filetype=bam	Illumina HiSeq 2500	5
EGAD00001008227	Whole genome sequencing for single cells for library A95664B 630 samples; filetype=bam	Illumina HiSeq 2500	5
EGAD00001008228	Whole genome sequencing for single cells for library A95707A 1359 samples; filetype=bam	HiSeq X Five	9
EGAD00001008229	Whole genome sequencing for single cells for library A95724A 503 samples; filetype=bam	NextSeq 550	5
EGAD00001008230	Whole genome sequencing for single cells for library A95724B 581 samples; filetype=bam	NextSeq 550	5
EGAD00001008231	Whole genome sequencing for single cells for library A95732B 655 samples; filetype=bam	HiSeq X Five	5
EGAD00001008232	Whole genome sequencing for single cells for library A96145A 642 samples; filetype=bam	HiSeq X Five	9
EGAD00001008233	Whole genome sequencing for single cells for library A96146A 1195 samples; filetype=bam	HiSeq X Five	5
EGAD00001008234	Whole genome sequencing for single cells for library A96149A 751 samples; filetype=bam	HiSeq X Five	5
EGAD00001008235	Whole genome sequencing for single cells for library A96149B 1792 samples; filetype=bam	HiSeq X Five	5
EGAD00001008236	Whole genome sequencing for single cells for library A96155B 1028 samples; filetype=bam	HiSeq X Five	5
EGAD00001008237	Whole genome sequencing for single cells for library A96157C 938 samples; filetype=bam	HiSeq X Five	7
EGAD00001008238	Whole genome sequencing for single cells for library A96162B 1316 samples; filetype=bam	HiSeq X Five	7
EGAD00001008239	Whole genome sequencing for single cells for library A96165A 779 samples; filetype=bam	HiSeq X Five	7
EGAD00001008240	Whole genome sequencing for single cells for library A96172A 1476 samples; filetype=bam	HiSeq X Five	7
EGAD00001008241	Whole genome sequencing for single cells for library A96172B 1694 samples; filetype=bam	HiSeq X Five	5
EGAD00001008242	Whole genome sequencing for single cells for library A96174B 1447 samples; filetype=bam	HiSeq X Five	7
EGAD00001008243	Whole genome sequencing for single cells for library A96175C 1473 samples; filetype=bam	HiSeq X Five	5
EGAD00001008244	Whole genome sequencing for single cells for library A96177B 683 samples; filetype=bam	HiSeq X Five	9
EGAD00001008245	Whole genome sequencing for single cells for library A96179B 1396 samples; filetype=bam	HiSeq X Five	7
EGAD00001008246	Whole genome sequencing for single cells for library A96180B 1189 samples; filetype=bam	HiSeq X Five	5
EGAD00001008247	Whole genome sequencing for single cells for library A96183C 1036 samples; filetype=bam	HiSeq X Five	5
EGAD00001008248	Whole genome sequencing for single cells for library A96184A 1733 samples; filetype=bam	HiSeq X Five	7
EGAD00001008249	Whole genome sequencing for single cells for library A96186A 850 samples; filetype=bam	HiSeq X Five	5
EGAD00001008250	Whole genome sequencing for single cells for library A96186C 525 samples; filetype=bam	HiSeq X Five	5
EGAD00001008251	Whole genome sequencing for single cells for library A96199B 1170 samples; filetype=bam	HiSeq X Five	5
EGAD00001008252	Whole genome sequencing for single cells for library A96201A 536 samples; filetype=bam	HiSeq X Five	5
EGAD00001008253	Whole genome sequencing for single cells for library A96205A 1907 samples; filetype=bam	HiSeq X Five	7
EGAD00001008254	Whole genome sequencing for single cells for library A96210C 1191 samples; filetype=bam	HiSeq X Five	5
EGAD00001008255	Whole genome sequencing for single cells for library A96211C 1397 samples; filetype=bam	HiSeq X Five	5
EGAD00001008256	Whole genome sequencing for single cells for library A96215A 1312 samples; filetype=bam	HiSeq X Five	5
EGAD00001008257	Whole genome sequencing for single cells for library A96216A 1001 samples; filetype=bam	HiSeq X Five	9
EGAD00001008258	Whole genome sequencing for single cells for library A96220B 1267 samples; filetype=bam	HiSeq X Five	5
EGAD00001008259	Whole genome sequencing for single cells for library A96244A 1374 samples; filetype=bam	HiSeq X Five	5
EGAD00001008260	Whole genome sequencing for single cells for library A98176A 1003 samples; filetype=bam	HiSeq X Five	5
EGAD00001008261	Whole genome sequencing for single cells for library A98176B 1389 samples; filetype=bam	HiSeq X Five	5
EGAD00001008262	Whole genome sequencing for single cells for library A98284A 1265 samples; filetype=bam	HiSeq X Five	4
EGAD00001008263	Whole genome sequencing for single cells for library A98284B 1582 samples; filetype=bam	HiSeq X Five	2
EGAD00001008264	Whole genome sequencing for single cells for library A98289B 1032 samples; filetype=bam	HiSeq X Five	5
EGAD00001008265	Whole genome sequencing for single cells for library A98293B 703 samples; filetype=bam	HiSeq X Five	5
EGAD00001008266	Whole genome sequencing for single cells for library A98294A 994 samples; filetype=bam	HiSeq X Five	5
EGAD00001008270	This dataset contains raw count data (10X CellRanger) for 28 Hodgkin lymphoma samples and 5 reactive lymph nodes, and merged data from all samples (RData object) including cell cluster assignments.		34
EGAD00001008431	Single-cell RNA-seq of first-, second-, and third-generation patient-derived organoids. Obtained using the 10X Genomics single-cell 3' expression solution (v3 chemistry). First- and second-generation PDOs from one patient and first-, second-, and third-generation PDOs from three additional patients.	Illumina NovaSeq 6000	11
EGAD00001008516	WGS and RNA-Seq data from a GBM patient PT-BM8772	Illumina HiSeq 2500	1
EGAD00001008517	WGS and RNA-Seq data from a GBM patient PT-CM3220	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001008518	WGS and RNA-Seq data from a GBM patient PT-DM9089	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001008519	WGS and RNA-Seq data from a GBM patient PT-GE7528	Illumina HiSeq 2000	1
EGAD00001008520	WGS and RNA-Seq data from a GBM patient PT-GI2070	Illumina HiSeq 2000	1
EGAD00001008521	WGS and RNA-Seq data from a GBM patient PT-JR9883	Illumina HiSeq 2000	1
EGAD00001008522	WGS and RNA-Seq data from a GBM patient PT-LC6372	Illumina HiSeq 2500	1
EGAD00001008523	WGS and RNA-Seq data from a GBM patient PT-ML9537	Illumina HiSeq 2500	1
EGAD00001008524	WGS data from a GBM patient PT-MS8478		-
EGAD00001008525	WGS and RNA-Seq data from a GBM patient PT-PR5617	Illumina HiSeq 2000 Illumina HiSeq 2500	2
EGAD00001008526	WGS and RNA-Seq data from a GBM patient PT-PV2594	Illumina HiSeq 2000 Illumina HiSeq 2500	5
EGAD00001008527	WGS and RNA-Seq data from a GBM patient PT-RV2286	Illumina HiSeq 2500	1
EGAD00001008528	WGS data from a GBM patient PT-SB3465		-
EGAD00001008529	WGS and RNA-Seq data from a GBM patient PT-SJ5453	Illumina HiSeq 2000 Illumina HiSeq 2500	3
EGAD00001008530	WGS and RNA-Seq data from a GBM patient PT-SS3647	Illumina HiSeq 2000 Illumina HiSeq 2500	3
EGAD00001008531	WGS and RNA-Seq data from a GBM patient PT-WR7927	Illumina HiSeq 2500	1
EGAD00001008532	WGS and RNA-Seq data from a GBM patient PT-WT4796	Illumina HiSeq 2000	1
EGAD00001008690	Long-read genome sequencing performed on the Oxford Nanopore Technologies' PromethION to resolve variants underlying breast cancer susceptibility in sixteen individuals with pathogenic germline SVs in BRCA1, BRCA2, CHEK2 or PALB2.	PromethION	16
EGAD00001008756	41 WGS DNA sequences from: Phase I trial of CX-5461, a first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies (CCTG IND.231)	Illumina HiSeq X	56
EGAD00001009111	10x Genomics Single Cell Gene Expression for Telomerase immortalized breast epithelium cell line 184-hTERT-22 L9 112.109	Illumina HiSeq 2500	1
EGAD00001009112	10x Genomics Single Cell Gene Expression for Telomerase immortalized breast epithelium cell line 184-hTERT-22 L9 116.126	Illumina HiSeq 2500	1
EGAD00001009113	10x Genomics Single Cell Gene Expression for Telomerase immortalized breast epithelium cell line 184-hTERT-22 L9 83.86	Illumina HiSeq 2500	1
EGAD00001009114	10x Genomics Single Cell Gene Expression for Telomerase immortalized breast epithelium cell line 184-hTert L9 116.66	Illumina HiSeq 2500	1
EGAD00001009115	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 4	BGISEQ-500	1
EGAD00001009116	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 6	Illumina HiSeq 2500	1
EGAD00001009117	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA604 passage 6	Illumina HiSeq 2500	1
EGAD00001009118	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA604 passage 8	Illumina HiSeq 2500	1
EGAD00001009119	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA604 passage 7	NextSeq 500	1
EGAD00001009120	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA609 passage 6	Illumina HiSeq 2500	1
EGAD00001009121	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1049 passage 1	NextSeq 500	1
EGAD00001009122	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1052 passage 1	NextSeq 500	1
EGAD00001009123	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1053 passage 1	NextSeq 500	1
EGAD00001009124	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1051 passage 1	NextSeq 500	1
EGAD00001009125	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1050 passage 1	NextSeq 500	1
EGAD00001009126	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1050 passage 1	NextSeq 500	1
EGAD00001009127	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1052 passage 1	NextSeq 500	1
EGAD00001009128	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1053 passage 1	Illumina HiSeq 2500	1
EGAD00001009129	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1093 passage 1	NextSeq 500	1
EGAD00001009130	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1091 passage 1	NextSeq 500	1
EGAD00001009131	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1053 passage 1	NextSeq 500	1
EGAD00001009132	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1096 passage 1	NextSeq 500	1
EGAD00001009133	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1051 passage 1	HiSeq X Ten	1
EGAD00001009134	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1052 passage 1	HiSeq X Ten	1
EGAD00001009135	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1181 passage 1	Illumina HiSeq 2500	1
EGAD00001009136	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1096 passage 1	Illumina HiSeq 2500	1
EGAD00001009137	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1096 passage 1	Illumina HiSeq 2500	1
EGAD00001009138	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1162 passage 1	Illumina HiSeq 2500	1
EGAD00001009139	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient SA1096	NextSeq 500	1
EGAD00001009140	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1049 passage 1	NextSeq 500	1
EGAD00001009141	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1050 passage 1	Illumina HiSeq 2500	1
EGAD00001009142	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA605 passage 3	NextSeq 500	1
EGAD00001009143	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma cell line OV2295	HiSeq X Ten	1
EGAD00001009144	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma cell line OV2295(R2)	HiSeq X Ten	1
EGAD00001009145	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient SA1184	NextSeq 500	1
EGAD00001009146	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma patient-derived xenograft SA1047 passage 1	HiSeq X Ten	1
EGAD00001009147	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 4	Illumina HiSeq 2500	1
EGAD00001009148	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 8	NextSeq 500	1
EGAD00001009149	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 6	BGISEQ-500	1
EGAD00001009150	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 6	Illumina HiSeq 2500	1
EGAD00001009151	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 7	HiSeq X Ten	1
EGAD00001009152	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 4	BGISEQ-500	1
EGAD00001009153	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 5	Illumina HiSeq 2500	1
EGAD00001009154	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA1035 passage 6	Illumina HiSeq 2500	1
EGAD00001009155	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 5	HiSeq X Ten	1
EGAD00001009156	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 5	HiSeq X Ten	1
EGAD00001009157	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA535 passage 9	Illumina HiSeq 2500	1
EGAD00001009158	10x Genomics Single Cell Gene Expression for High grade serous ovarian carcinoma cell line TOV2295(R)	HiSeq X Ten	1
EGAD00001009159	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA604 passage 9	NextSeq 500	1
EGAD00001009160	10x Genomics Single Cell Gene Expression for Triple negative breast cancer patient-derived xenograft SA610 passage 3	HiSeq X Ten	1
EGAD00001009177	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA218	Illumina HiSeq 2500	1
EGAD00001009178	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA219	Illumina HiSeq 2500	1
EGAD00001009179	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA272	Illumina HiSeq 2500	1
EGAD00001009180	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA274	Illumina HiSeq 2500	1
EGAD00001009181	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA275	Illumina HiSeq 2500	1
EGAD00001009182	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA276	Illumina HiSeq 2500	1
EGAD00001009183	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA279	Illumina HiSeq 2500	1
EGAD00001009184	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA283	Illumina HiSeq 2500	1
EGAD00001009185	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA287	Illumina HiSeq 2500	1
EGAD00001009186	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA394	Illumina HiSeq 2500	1
EGAD00001009187	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA395	Illumina HiSeq 2500	1
EGAD00001009188	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA398	Illumina HiSeq 2500	1
EGAD00001009189	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA402	Illumina HiSeq 2500	1
EGAD00001009190	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA404	Illumina HiSeq 2500	1
EGAD00001009191	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA530	Illumina HiSeq 2000	1
EGAD00001009192	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA585	Illumina HiSeq 2500	1
EGAD00001009193	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA586	Illumina HiSeq 2500	1
EGAD00001009194	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA588	Illumina HiSeq 2500	1
EGAD00001009195	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA589	Illumina HiSeq 2500	1
EGAD00001009196	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA590	Illumina HiSeq 2500	1
EGAD00001009197	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA591	Illumina HiSeq 2500	1
EGAD00001009198	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA592	Illumina HiSeq 2500	1
EGAD00001009199	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA593	Illumina HiSeq 2500	1
EGAD00001009200	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA595	Illumina HiSeq 2500	1
EGAD00001009201	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA596	Illumina HiSeq 2500	1
EGAD00001009202	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA598	Illumina HiSeq 2500	1
EGAD00001009203	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA599	Illumina HiSeq 2500	1
EGAD00001009204	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA600	Illumina HiSeq 2500	1
EGAD00001009205	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA601	Illumina HiSeq 2500	1
EGAD00001009206	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA654	Illumina HiSeq 2500	1
EGAD00001009207	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA655	Illumina HiSeq 2500	1
EGAD00001009208	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA665	Illumina HiSeq 2500	1
EGAD00001009209	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA666	Illumina HiSeq 2500	1
EGAD00001009210	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA667	Illumina HiSeq 2500	1
EGAD00001009211	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA668	Illumina HiSeq 2500	1
EGAD00001009212	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA669	Illumina HiSeq 2500	1
EGAD00001009213	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA671	Illumina HiSeq 2500	1
EGAD00001009214	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA672	Illumina HiSeq 2500	1
EGAD00001009215	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA535	Illumina HiSeq 2000	1
EGAD00001009216	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1035	Illumina HiSeq X	1
EGAD00001009217	Whole genome sequencing of normal sample for triple negative breast cancer patient SA604	Illumina HiSeq 2500	1
EGAD00001009218	Whole genome sequencing of normal sample for triple negative breast cancer patient SA605	Illumina HiSeq 2500	1
EGAD00001009219	Whole genome sequencing of normal sample for triple negative breast cancer patient SA609	Illumina HiSeq 2500	1
EGAD00001009220	Whole genome sequencing of normal sample for triple negative breast cancer patient SA218	Illumina HiSeq 2500	1
EGAD00001009221	Whole genome sequencing of normal sample for triple negative breast cancer patient SA219	Illumina HiSeq 2500	1
EGAD00001009222	Whole genome sequencing of normal sample for triple negative breast cancer patient SA272	Illumina HiSeq 2500	1
EGAD00001009223	Whole genome sequencing of normal sample for triple negative breast cancer patient SA274	Illumina HiSeq 2500	1
EGAD00001009224	Whole genome sequencing of normal sample for triple negative breast cancer patient SA275	Illumina HiSeq 2500	1
EGAD00001009225	Whole genome sequencing of normal sample for triple negative breast cancer patient SA276	Illumina HiSeq 2500	1
EGAD00001009226	Whole genome sequencing of normal sample for triple negative breast cancer patient SA279	Illumina HiSeq 2500	1
EGAD00001009227	Whole genome sequencing of normal sample for triple negative breast cancer patient SA283	Illumina HiSeq 2500	1
EGAD00001009228	Whole genome sequencing of normal sample for triple negative breast cancer patient SA287	Illumina HiSeq 2500	1
EGAD00001009229	Whole genome sequencing of normal sample for triple negative breast cancer patient SA394	Illumina HiSeq 2500	1
EGAD00001009230	Whole genome sequencing of normal sample for triple negative breast cancer patient SA395	Illumina HiSeq 2500	1
EGAD00001009231	Whole genome sequencing of normal sample for triple negative breast cancer patient SA398	Illumina HiSeq 2500	1
EGAD00001009232	Whole genome sequencing of normal sample for triple negative breast cancer patient SA402	Illumina HiSeq 2500	1
EGAD00001009233	Whole genome sequencing of normal sample for triple negative breast cancer patient SA404	Illumina HiSeq 2500	1
EGAD00001009234	Whole genome sequencing of normal sample for triple negative breast cancer patient SA530	Illumina HiSeq 2500	1
EGAD00001009235	Whole genome sequencing of normal sample for triple negative breast cancer patient SA535	Illumina HiSeq 2000	1
EGAD00001009236	Whole genome sequencing of normal sample for triple negative breast cancer patient SA585	Illumina HiSeq 2500	1
EGAD00001009237	Whole genome sequencing of normal sample for triple negative breast cancer patient SA586	Illumina HiSeq 2500	1
EGAD00001009238	Whole genome sequencing of normal sample for triple negative breast cancer patient SA588	Illumina HiSeq 2500	1
EGAD00001009239	Whole genome sequencing of normal sample for triple negative breast cancer patient SA589	Illumina HiSeq 2500	1
EGAD00001009240	Whole genome sequencing of normal sample for triple negative breast cancer patient SA590	Illumina HiSeq 2500	1
EGAD00001009241	Whole genome sequencing of normal sample for triple negative breast cancer patient SA591	Illumina HiSeq 2500	1
EGAD00001009242	Whole genome sequencing of normal sample for triple negative breast cancer patient SA592	Illumina HiSeq 2500	1
EGAD00001009243	Whole genome sequencing of normal sample for triple negative breast cancer patient SA593	Illumina HiSeq 2500	1
EGAD00001009244	Whole genome sequencing of normal sample for triple negative breast cancer patient SA595	Illumina HiSeq 2500	1
EGAD00001009245	Whole genome sequencing of normal sample for triple negative breast cancer patient SA596	Illumina HiSeq 2500	1
EGAD00001009246	Whole genome sequencing of normal sample for triple negative breast cancer patient SA598	Illumina HiSeq 2500	1
EGAD00001009247	Whole genome sequencing of normal sample for triple negative breast cancer patient SA599	Illumina HiSeq 2500	1
EGAD00001009248	Whole genome sequencing of normal sample for triple negative breast cancer patient SA600	Illumina HiSeq 2500	1
EGAD00001009249	Whole genome sequencing of normal sample for triple negative breast cancer patient SA601	Illumina HiSeq 2500	1
EGAD00001009250	Whole genome sequencing of normal sample for triple negative breast cancer patient SA654	Illumina HiSeq 2500	1
EGAD00001009251	Whole genome sequencing of normal sample for triple negative breast cancer patient SA655	Illumina HiSeq 2500	1
EGAD00001009252	Whole genome sequencing of normal sample for triple negative breast cancer patient SA665	Illumina HiSeq 2500	1
EGAD00001009253	Whole genome sequencing of normal sample for triple negative breast cancer patient SA667	Illumina HiSeq 2500	1
EGAD00001009254	Whole genome sequencing of normal sample for triple negative breast cancer patient SA668	Illumina HiSeq 2500	1
EGAD00001009255	Whole genome sequencing of normal sample for triple negative breast cancer patient SA669	Illumina HiSeq 2500	1
EGAD00001009256	Whole genome sequencing of normal sample for triple negative breast cancer patient SA671	Illumina HiSeq 2500	1
EGAD00001009257	Whole genome sequencing of normal sample for triple negative breast cancer patient SA672	Illumina HiSeq 2500	1
EGAD00001009258	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1035	Illumina HiSeq X	1
EGAD00001009259	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA994	Illumina HiSeq X	1
EGAD00001009260	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA604	Illumina HiSeq 2500	1
EGAD00001009261	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA605	Illumina HiSeq 2500	1
EGAD00001009262	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA609	Illumina HiSeq 2500	1
EGAD00001009316	Single Cell Genome Sequence for Triple negative breast cancer patient-derived xenograft SA609 passage 3 on DLP+ library A95618B	NextSeq 550	15
EGAD00001009319	Single Cell Genome Sequence for triple negative breast cancer patient SA1162SB on DLP+ library A95628A	HiSeq X Ten	3
EGAD00001009320	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1051D passage 1 on DLP+ library A95629B	HiSeq X Ten	3
EGAD00001009321	Single Cell Genome Sequence for immortalized breast epithelium - BRCA1-/- Tp53-/- cell line 184-hTERT-22 L9 83.86 on DLP+ library A95632A	Illumina HiSeq 2500	7
EGAD00001009322	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA609 passage 6 on DLP+ library A95632C	NextSeq 550	8
EGAD00001009323	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1091A passage 1 on DLP+ library A95634A	HiSeq X Ten	3
EGAD00001009324	Single Cell Genome Sequence for immortalized breast epithelium - BRCA2-/-; Tp53-/- cell line 184-hTERT-22 L9 116.126 on DLP+ library A95635A	Illumina HiSeq 2500	4
EGAD00001009325	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1052J passage 1 on DLP+ library A95650A	HiSeq X Ten	3
EGAD00001009326	Single Cell Genome Sequence for immortalized breast epithelium BRCA2+/- Tp53-/- cell line 184-hTert L9 116.66 on DLP+ library A95652A	HiSeq X Ten	2
EGAD00001009327	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1049A passage 1 on DLP+ library A95652B	HiSeq X Ten	3
EGAD00001009340	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA673	Illumina HiSeq 2500	1
EGAD00001009341	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA674	Illumina HiSeq 2500	1
EGAD00001009342	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA675	Illumina HiSeq 2500	1
EGAD00001009343	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA676	Illumina HiSeq 2500	1
EGAD00001009344	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA677	Illumina HiSeq 2500	1
EGAD00001009345	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA678	Illumina HiSeq 2500	1
EGAD00001009346	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA679	Illumina HiSeq 2500	1
EGAD00001009347	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA680	Illumina HiSeq 2500	1
EGAD00001009348	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA681	Illumina HiSeq 2500	1
EGAD00001009349	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA682	Illumina HiSeq 2500	1
EGAD00001009350	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA683	Illumina HiSeq 2500	1
EGAD00001009351	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA221	Illumina HiSeq 2000	1
EGAD00001009352	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA238	Illumina HiSeq 2000	1
EGAD00001009353	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA239	Illumina HiSeq 2000	1
EGAD00001009354	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA300	Illumina HiSeq 2000	1
EGAD00001009355	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA423	Illumina HiSeq 2000	1
EGAD00001009356	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA425	Illumina HiSeq 2000	1
EGAD00001009357	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA495	Illumina HiSeq 2000	1
EGAD00001009358	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA286	Illumina HiSeq 2000	1
EGAD00001009359	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA289	Illumina HiSeq 2000	1
EGAD00001009360	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA291	Illumina HiSeq 2000	1
EGAD00001009361	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA280	Illumina HiSeq 2000	1
EGAD00001009362	Whole genome sequencing of normal sample for triple negative breast cancer patient SA221	Illumina HiSeq 2000	1
EGAD00001009363	Whole genome sequencing of normal sample for triple negative breast cancer patient SA238	Illumina HiSeq 2000	1
EGAD00001009364	Whole genome sequencing of normal sample for triple negative breast cancer patient SA239	Illumina HiSeq 2000	1
EGAD00001009365	Whole genome sequencing of normal sample for triple negative breast cancer patient SA280	Illumina HiSeq 2000	1
EGAD00001009366	Whole genome sequencing of normal sample for triple negative breast cancer patient SA286	Illumina HiSeq 2000	1
EGAD00001009367	Whole genome sequencing of normal sample for triple negative breast cancer patient SA289	Illumina HiSeq 2000	1
EGAD00001009368	Whole genome sequencing of normal sample for triple negative breast cancer patient SA291	Illumina HiSeq 2000	1
EGAD00001009369	Whole genome sequencing of normal sample for triple negative breast cancer patient SA300	Illumina HiSeq 2000	1
EGAD00001009370	Whole genome sequencing of normal sample for triple negative breast cancer patient SA423	Illumina HiSeq 2000	1
EGAD00001009371	Whole genome sequencing of normal sample for triple negative breast cancer patient SA425	Illumina HiSeq 2000	1
EGAD00001009372	Whole genome sequencing of normal sample for triple negative breast cancer patient SA495	Illumina HiSeq 2000	1
EGAD00001009373	Whole genome sequencing of normal sample for triple negative breast cancer patient SA673	Illumina HiSeq 2500	1
EGAD00001009374	Whole genome sequencing of normal sample for triple negative breast cancer patient SA674	Illumina HiSeq 2500	1
EGAD00001009375	Whole genome sequencing of normal sample for triple negative breast cancer patient SA675	Illumina HiSeq 2500	1
EGAD00001009376	Whole genome sequencing of normal sample for triple negative breast cancer patient SA676	Illumina HiSeq 2500	1
EGAD00001009377	Whole genome sequencing of normal sample for triple negative breast cancer patient SA677	Illumina HiSeq 2500	1
EGAD00001009378	Whole genome sequencing of normal sample for triple negative breast cancer patient SA678	Illumina HiSeq 2500	1
EGAD00001009379	Whole genome sequencing of normal sample for triple negative breast cancer patient SA679	Illumina HiSeq 2500	1
EGAD00001009380	Whole genome sequencing of normal sample for triple negative breast cancer patient SA680	Illumina HiSeq 2500	1
EGAD00001009381	Whole genome sequencing of normal sample for triple negative breast cancer patient SA681	Illumina HiSeq 2500	1
EGAD00001009382	Whole genome sequencing of normal sample for triple negative breast cancer patient SA682	Illumina HiSeq 2500	1
EGAD00001009383	Whole genome sequencing of normal sample for triple negative breast cancer patient SA683	Illumina HiSeq 2500	1
EGAD00001009428	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1181A passage 1 on DLP library A108765A	HiSeq X Ten	3
EGAD00001009429	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1182E passage 1 on DLP+ library A108847B	HiSeq X Ten	4
EGAD00001009430	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA610 passage 3 on DLP+ library A110660A	HiSeq X Ten	4
EGAD00001009431	Single Cell Genome Sequence for Immortalized breast epithelium BRCA2+/- Tp53-/- cell line 184-hTert L9 116.66 cell line SA1188 on DLP+ library A118357B	HiSeq X Ten	3
EGAD00001009432	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA605 passage 3 on DLP+ library A118368B	HiSeq X Ten	4
EGAD00001009433	Single Cell Genome Sequence for Telomerase immortalized breast epithelium cell line 184-hTERT 85.14 p20 cell line AT135 on DLP+ library A118389B	NextSeq 2000	4
EGAD00001009434	Single Cell Genome Sequence for Immortalized breast epithelium BRCA2+/- Tp53-/- cell line 184-hTert L9 116.66 cell line SA1188 on DLP+ library A118425B	HiSeq X Ten	3
EGAD00001009435	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1050B passage 1, patient-derived xenograft SA1050E passage 1 on DLP+ library A118782A	HiSeq X Ten	6
EGAD00001009436	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1050B passage 1, patient-derived xenograft SA1050E passage 1 on DLP+ library A118784A	HiSeq X Ten	6
EGAD00001009437	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA610 passage 3, patient-derived xenograft SA1096C passage 1 on DLP+ library A118790A	HiSeq X Ten	6
EGAD00001009438	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1184D passage 1 on DLP+ library A118797B	HiSeq X Ten	4
EGAD00001009439	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1162B passage 1, patient-derived xenograft SA1096B passage 1 on DLP+ library A118804A	HiSeq X Ten	6
EGAD00001009440	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1096B passage 1 on DLP+ library A118808A	HiSeq X Ten	4
EGAD00001009441	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1096C passage 1 on DLP+ library A118808B	HiSeq X Ten	4
EGAD00001009442	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1180C passage 1 on DLP+ library A118812B	HiSeq X Ten	4
EGAD00001009443	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1162B passage 1 on DLP+ library A118814B	HiSeq X Ten	4
EGAD00001009444	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1180C passage 1 on DLP+ library A118816A	HiSeq X Ten	4
EGAD00001009445	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1184D passage 1 on DLP+ library A118857B	HiSeq X Ten	4
EGAD00001009446	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1053F passage 1 on DLP+ library A95663A	HiSeq X Ten	3
EGAD00001009447	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1162SA on DLP+ library A95668A	HiSeq X Ten	3
EGAD00001009448	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 5 on DLP+ library A95670A	NextSeq 550	3
EGAD00001009449	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 6 on DLP+ library A95670B	NextSeq 550	3
EGAD00001009450	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1096A passage 1 on DLP+ library A95717A	HiSeq X Ten	3
EGAD00001009451	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 6 on DLP+ library A95722A	HiSeq X Ten	7
EGAD00001009452	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 2 on DLP+ library A96109A	HiSeq X Ten	5
EGAD00001009453	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1049A passage on DLP+ library A96113A	NextSeq 550	6
EGAD00001009454	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA609 passage 8 on DLP+ library A96130A	HiSeq X Ten	3
EGAD00001009455	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1162SA on DLP+ library A96142B	HiSeq X Ten	3
EGAD00001009456	Single Cell Genome Sequence for triple negative breast cancer patient SA1135, patient SA1162SA on DLP+ library A96154A	HiSeq X Ten	5
EGAD00001009457	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 8 on DLP+ library A96161A	HiSeq X Ten	5
EGAD00001009458	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 2, patient-derived xenograft SA611 passage 3 on DLP+ library A96171A	HiSeq X Ten	7
EGAD00001009459	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 15 on DLP+ library A96173A	HiSeq X Ten	7
EGAD00001009460	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 11 on DLP+ library A96174A	HiSeq X Ten	3
EGAD00001009461	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 7 on DLP+ library A96175A	HiSeq X Ten	3
EGAD00001009462	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 6 on DLP+ library A96177C	HiSeq X Ten	3
EGAD00001009463	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 6 on DLP+ library A96180A	HiSeq X Ten	3
EGAD00001009464	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 11, patient-derived xenograft SA609 passage 7 on DLP+ library A96187A	HiSeq X Ten	10
EGAD00001009465	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1049C passage 1 on DLP+ library A96189A	HiSeq X Ten	3
EGAD00001009466	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1051A passage 1 on DLP+ library A96190B	HiSeq X Ten	3
EGAD00001009467	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1093C passage 1, patient SA1147 on DLP+ library A96192A	HiSeq X Ten	5
EGAD00001009468	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1053B passage 1 on DLP+ library A96194A	HiSeq X Ten	3
EGAD00001009469	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1053E passage 1 on DLP+ library A96194B	HiSeq X Ten	3
EGAD00001009470	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1052D passage 1 on DLP+ library A96200B	HiSeq X Ten	3
EGAD00001009471	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1049A passage 1 on DLP+ library A96205B	HiSeq X Ten	-
EGAD00001009472	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1050F passage 1 on DLP+ library A96206B	HiSeq X Ten	3
EGAD00001009473	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1051A passage 1 on DLP+ library A96207A	HiSeq X Ten	3
EGAD00001009474	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1052B passage 1 on DLP+ library A96207B	HiSeq X Ten	3
EGAD00001009475	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1047B on DLP+ library A96210B	HiSeq X Ten	3
EGAD00001009476	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 7 on DLP+ library A96212B	HiSeq X Ten	5
EGAD00001009477	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 6, cell line SA1090 on DLP+ library A96213A	HiSeq X Ten	5
EGAD00001009478	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1105, patient SA1103, patient SA1106, patient SA1104 on DLP+ library A96222A	NextSeq 550	11
EGAD00001009479	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA919 passage 7, patient-derived xenograft SA1050A passage 1 on DLP+ library A98181A	HiSeq X Ten	6
EGAD00001009480	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA530 passage 3 on DLP+ library A98240A	HiSeq X Ten	4
EGAD00001009481	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1096A, patient-derived xenograft SA1052D passage 1 on DLP+ library A98243B	HiSeq X Ten	6
EGAD00001009486	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1050A passage 1, patient SA1234 on DLP+ library A98279A	HiSeq X Ten	-
EGAD00001009487	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA501 passage 2 on DLP+ library A95621B	Illumina HiSeq 2500	1
EGAD00001009488	Single Cell Genome Sequence for Immortalized breast epithelium - BRCA2-/-; Tp53-/- cell line 184-hTERT-22 L9 112.109 cell line SA1055 on DLP+ library A95621A	Illumina HiSeq 2500	3
EGAD00001009489	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient-derived xenograft SA1050D passage 1 on DLP+ library A95717B	HiSeq X Ten	3
EGAD00001009513	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 8 on DLP+ library A96141A	HiSeq X Ten	212
EGAD00001009517	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA533	Illumina HiSeq 2000	1
EGAD00001009518	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA409	Illumina HiSeq 2500	1
EGAD00001009519	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA420	Illumina HiSeq 2000	1
EGAD00001009520	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA296	Illumina HiSeq 2500	1
EGAD00001009521	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA597	Illumina HiSeq 2500	1
EGAD00001009522	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA232	Illumina HiSeq 2000	1
EGAD00001009523	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA211	Illumina HiSeq X	1
EGAD00001009524	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA230	Illumina HiSeq X	1
EGAD00001009525	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA234	Illumina HiSeq X	1
EGAD00001009526	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA278	Illumina HiSeq X	1
EGAD00001009527	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA101	Illumina HiSeq X	1
EGAD00001009528	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA212	Illumina HiSeq X	1
EGAD00001009529	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA214	Illumina HiSeq X	1
EGAD00001009530	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA224	Illumina HiSeq X	1
EGAD00001009531	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA225	Illumina HiSeq X	1
EGAD00001009532	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA226	Illumina HiSeq X	1
EGAD00001009533	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA228	Illumina HiSeq X	1
EGAD00001009534	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA229	Illumina HiSeq X	1
EGAD00001009535	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA231	Illumina HiSeq X	1
EGAD00001009536	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA233	Illumina HiSeq X	1
EGAD00001009537	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA237	Illumina HiSeq X	1
EGAD00001009538	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA271	Illumina HiSeq X	1
EGAD00001009539	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA277	Illumina HiSeq X	1
EGAD00001009540	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA284	Illumina HiSeq X	1
EGAD00001009541	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA399	Illumina HiSeq X	1
EGAD00001009542	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA294	Illumina HiSeq X	1
EGAD00001009543	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA285	Illumina HiSeq 2000	1
EGAD00001009544	Whole genome sequencing of normal sample for triple negative breast cancer patient SA101	Illumina HiSeq X	1
EGAD00001009545	Whole genome sequencing of normal sample for triple negative breast cancer patient SA211	Illumina HiSeq X	1
EGAD00001009546	Whole genome sequencing of normal sample for triple negative breast cancer patient SA212	Illumina HiSeq X	1
EGAD00001009547	Whole genome sequencing of normal sample for triple negative breast cancer patient SA214	Illumina HiSeq X	1
EGAD00001009548	Whole genome sequencing of normal sample for triple negative breast cancer patient SA224	Illumina HiSeq X	1
EGAD00001009549	Whole genome sequencing of normal sample for triple negative breast cancer patient SA225	Illumina HiSeq X	1
EGAD00001009550	Whole genome sequencing of normal sample for triple negative breast cancer patient SA226	Illumina HiSeq X	1
EGAD00001009551	Whole genome sequencing of normal sample for triple negative breast cancer patient SA228	Illumina HiSeq X	1
EGAD00001009552	Whole genome sequencing of normal sample for triple negative breast cancer patient SA229	Illumina HiSeq X	1
EGAD00001009553	Whole genome sequencing of normal sample for triple negative breast cancer patient SA230	Illumina HiSeq X	1
EGAD00001009554	Whole genome sequencing of normal sample for triple negative breast cancer patient SA231	Illumina HiSeq X	1
EGAD00001009555	Whole genome sequencing of normal sample for triple negative breast cancer patient SA232	Illumina HiSeq 2000	1
EGAD00001009556	Whole genome sequencing of normal sample for triple negative breast cancer patient SA233	Illumina HiSeq X	1
EGAD00001009557	Whole genome sequencing of normal sample for triple negative breast cancer patient SA234	Illumina HiSeq X	1
EGAD00001009558	Whole genome sequencing of normal sample for triple negative breast cancer patient SA237	Illumina HiSeq X	1
EGAD00001009559	Whole genome sequencing of normal sample for triple negative breast cancer patient SA271	Illumina HiSeq X	1
EGAD00001009560	Whole genome sequencing of normal sample for triple negative breast cancer patient SA277	Illumina HiSeq X	1
EGAD00001009561	Whole genome sequencing of normal sample for triple negative breast cancer patient SA278	Illumina HiSeq X	1
EGAD00001009562	Whole genome sequencing of normal sample for triple negative breast cancer patient SA284	Illumina HiSeq X	1
EGAD00001009563	Whole genome sequencing of normal sample for triple negative breast cancer patient SA285	Illumina HiSeq 2500	1
EGAD00001009564	Whole genome sequencing of normal sample for triple negative breast cancer patient SA290	Illumina HiSeq 2500	1
EGAD00001009565	Whole genome sequencing of normal sample for triple negative breast cancer patient SA294	Illumina HiSeq X	1
EGAD00001009566	Whole genome sequencing of normal sample for triple negative breast cancer patient SA296	Illumina HiSeq 2500	1
EGAD00001009567	Whole genome sequencing of normal sample for triple negative breast cancer patient SA399	Illumina HiSeq X	1
EGAD00001009568	Whole genome sequencing of normal sample for triple negative breast cancer patient SA400	Illumina HiSeq X	1
EGAD00001009569	Whole genome sequencing of normal sample for triple negative breast cancer patient SA409	Illumina HiSeq 2500	1
EGAD00001009570	Whole genome sequencing of normal sample for triple negative breast cancer patient SA420	Illumina HiSeq 2500	1
EGAD00001009571	Whole genome sequencing of normal sample for triple negative breast cancer patient SA533	Illumina HiSeq 2000	1
EGAD00001009572	Whole genome sequencing of normal sample for triple negative breast cancer patient SA597	Illumina HiSeq 2500	1
EGAD00001009573	Whole genome sequencing of normal sample for triple negative breast cancer patient SA997	Illumina HiSeq X	1
EGAD00001009574	Whole genome sequencing of normal sample for triple negative breast cancer patient SA998	Illumina HiSeq X	1
EGAD00001009575	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA416	Illumina HiSeq X	1
EGAD00001009576	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA400	Illumina HiSeq X	1
EGAD00001009577	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA290	Illumina HiSeq 2000	1
EGAD00001009578	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA288	Illumina HiSeq 2500	1
EGAD00001009579	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA299	Illumina HiSeq 2000	1
EGAD00001009580	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA095	Illumina HiSeq 2000	1
EGAD00001009581	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA415	Illumina HiSeq X	1
EGAD00001009582	Whole genome sequencing of normal sample for triple negative breast cancer patient SA718	Illumina HiSeq 2500	1
EGAD00001009583	Whole genome sequencing of normal sample for triple negative breast cancer patient SA720	Illumina HiSeq 2500	1
EGAD00001009584	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA718	Illumina HiSeq 2500	1
EGAD00001009585	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA720	Illumina HiSeq 2500	1
EGAD00001009586	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1017	Illumina HiSeq X	1
EGAD00001009587	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1026	Illumina HiSeq X	1
EGAD00001009588	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1027	Illumina HiSeq X	1
EGAD00001009589	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1028	Illumina HiSeq X	1
EGAD00001009590	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1040	Illumina HiSeq X	1
EGAD00001009591	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1064	Illumina HiSeq X	1
EGAD00001009592	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1065	Illumina HiSeq X	1
EGAD00001009593	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1069	Illumina HiSeq X	1
EGAD00001009594	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1073	Illumina HiSeq X	1
EGAD00001009595	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1074	Illumina HiSeq X	1
EGAD00001009596	Whole genome sequencing of normal sample for triple negative breast cancer patient SA576	Illumina HiSeq 2000	1
EGAD00001009597	Whole genome sequencing of normal sample for triple negative breast cancer patient SA610	Illumina HiSeq 2500	1
EGAD00001009598	Whole genome sequencing of normal sample for triple negative breast cancer patient SA992	Illumina HiSeq X	1
EGAD00001009599	Whole genome sequencing of normal sample for triple negative breast cancer patient SA994	Illumina HiSeq X	1
EGAD00001009600	Whole genome sequencing of normal sample for triple negative breast cancer patient SA095	Illumina HiSeq 2000	1
EGAD00001009601	Whole genome sequencing of normal sample for triple negative breast cancer patient SA288	Illumina HiSeq 2500	1
EGAD00001009602	Whole genome sequencing of normal sample for triple negative breast cancer patient SA299	Illumina HiSeq 2000	1
EGAD00001009603	Whole genome sequencing of normal sample for triple negative breast cancer patient SA415	Illumina HiSeq X	1
EGAD00001009604	Whole genome sequencing of normal sample for triple negative breast cancer patient SA666	Illumina HiSeq 2500	1
EGAD00001009605	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1065	Illumina HiSeq X	1
EGAD00001009606	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1064	Illumina HiSeq X	1
EGAD00001009607	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1026	Illumina HiSeq X	1
EGAD00001009608	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1069	Illumina HiSeq X	1
EGAD00001009609	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1017	Illumina HiSeq X	1
EGAD00001009610	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1027	Illumina HiSeq X	1
EGAD00001009611	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1073	Illumina HiSeq X	1
EGAD00001009612	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1074	Illumina HiSeq X	1
EGAD00001009613	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA576	Illumina HiSeq 2500	1
EGAD00001009614	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1028	Illumina HiSeq X	1
EGAD00001009615	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1040	Illumina HiSeq X	1
EGAD00001009616	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA992	Illumina HiSeq X	1
EGAD00001009617	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA610	Illumina HiSeq 2500	1
EGAD00001009618	Whole genome sequencing of normal sample for triple negative breast cancer patient SA416	Illumina HiSeq X	1
EGAD00001009619	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1070	Illumina HiSeq X	1
EGAD00001009620	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1070	Illumina HiSeq X	1
EGAD00001009621	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA997	Illumina HiSeq X	1
EGAD00001009644	Single Cell Genome Sequence for high grade serous ovarian carcinoma patient SA1105, patient SA1106 on DLP+ library A96168B	HiSeq X Ten	5
EGAD00001009645	Single Cell Genome Sequence for Immortalized lymphoblastoid cell line GM18507 cell line SA928,Triple negative breast cancer patient-derived xenograft SA609 passage 2 patient-derived xenograft SA609 passage 2 on DLP+ library A96228A	HiSeq X Ten	6
EGAD00001009646	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA530 passage 3 on DLP+ library A98247A	HiSeq X Ten	-
EGAD00001009650	This data set includes RNAseq from 38 follicular lymphoma tumours. All tumours were fresh frozen. Libraries were constructed by enriching for poly-A transcripts and sequenced as 75bp paired end reads on an Illumina HiSeq 2500 instrument.	Illumina HiSeq 2500	38
EGAD00001009672	Whole genome sequencing of normal sample for triple negative breast cancer patient SA1058	Illumina HiSeq X	1
EGAD00001009673	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1058	Illumina HiSeq X	1
EGAD00001009674	Whole genome sequencing of tumour sample for triple negative breast cancer patient SA998	Illumina HiSeq X	1
EGAD00001009749	This dataset includes 4 samples profiled by high-throughput Illumina sequencing, in bam format, aligned to GRCh37. Human patient T-ALL samples were serially propagated as xenografts in immunodeficient mice. The samples were collected after development of frank leukemia in recipient mice.	Illumina HiSeq 2500	4
EGAD00001009750	This dataset includes 90 samples profiled by high-throughput Illumina sequencing, in bam format, aligned to GRCh37. Normal human CD34+ cord blood (CB), bone marrow (BM), or post-natal thymus (PNT) cells were transduced with various combinations of T-ALL oncogenes and cultured in vitro.	Illumina HiSeq 2500	90
EGAD00001009751	This dataset includes 73 samples profiled by high-throughput Illumina sequencing, in bam format, aligned to GRCh37. Normal human CD34+ cord blood (CB), bone marrow (BM), or post-natal thymus (PNT) cells were transduced with various combinations of T-ALL oncogenes, cultured in vitro on OP9-DL1 feeders for up to 25 days, and then transplanted into immunodeficient NSG or NRG mice. The samples were collected after development of frank leukemia in recipient mice.	Illumina HiSeq 2500	73
EGAD00001009772	miRNA libraries of the AML-PMP project were sequenced on the Illumina HiSeq 2000 instrument, approximately 16 samples per HiSeq lane, to a median depth of 5.7 million reads per library.	Illumina HiSeq 2000	1
EGAD00001009777	Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA604 passage 8 on DLP+ library A96141A	HiSeq X Ten	1
EGAD00001010204	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0167_003 for Follicular lymphoma patient sample TFRI_Cont_2	Illumina HiSeq 2500	1
EGAD00001010205	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0168_003 for Follicular lymphoma patient sample TFRI_Cont_3	Illumina HiSeq 2500	1
EGAD00001010206	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0169_003 for Follicular lymphoma patient sample TFRI_Cont_4	Illumina HiSeq 2500	1
EGAD00001010207	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0170_003 for Follicular lymphoma patient sample TFRI_Cont_5	Illumina HiSeq 2500	1
EGAD00001010208	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0171_003A for Follicular lymphoma patient sample TFRI_Cont_6	Illumina HiSeq 2500	1
EGAD00001010209	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0178_003A for Follicular lymphoma patient sample TFRI_Cont_8	Illumina HiSeq 2500	1
EGAD00001010210	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0183_003A for Follicular lymphoma patient sample TFRI_Cont_9	Illumina HiSeq 2500	1
EGAD00001010211	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0187_003A for Follicular lymphoma patient sample TFRI_Cont_10	Illumina HiSeq 2500	1
EGAD00001010212	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0188_003A for Follicular lymphoma patient sample TFRI_Cont_11	Illumina HiSeq 2500	1
EGAD00001010213	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0197_003A for Follicular lymphoma patient sample TFRI_Cont_12	Illumina HiSeq 2500	1
EGAD00001010214	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0198_003A for Follicular lymphoma patient sample TFRI_Cont_13	Illumina HiSeq 2500	1
EGAD00001010215	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0167_001 for Follicular lymphoma patient sample TFRIPAIR2_FL	Illumina HiSeq 2500	1
EGAD00001010216	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0168_001 for Follicular lymphoma patient sample TFRIPAIR3_FL	Illumina HiSeq 2500	1
EGAD00001010217	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0169_001 for Follicular lymphoma patient sample TFRIPAIR4_FL	Illumina HiSeq 2500	1
EGAD00001010218	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0170_001A for Follicular lymphoma patient sample TFRIPAIR5_FL	Illumina HiSeq 2500	1
EGAD00001010219	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0171_001A for Follicular lymphoma patient sample TFRI_Pair_6_FL	Illumina HiSeq 2500	1
EGAD00001010220	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0178_001A for Follicular lymphoma patient sample TFRIPAIR8_FL	Illumina HiSeq 2500	1
EGAD00001010221	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0183_001A for Follicular lymphoma patient sample TFRIPAIR9_FL	Illumina HiSeq 2500	1
EGAD00001010222	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0187_001A for Follicular lymphoma patient sample TFRIPAIR10_FL	Illumina HiSeq 2500	1
EGAD00001010223	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0188_001A for Follicular lymphoma patient sample TFRIPAIR11_FL	Illumina HiSeq 2500	1
EGAD00001010224	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0197_001A for Follicular lymphoma patient sample TFRIPAIR12_FL	Illumina HiSeq 2500	1
EGAD00001010225	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0198_001A for Follicular lymphoma patient sample TFRI_Pair_13_FL	Illumina HiSeq 2500	1
EGAD00001010226	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0167_002 for Diffuse large B-cell lymphoma patient sample TFRIPAIR2_DLBCL	Illumina HiSeq 2500	1
EGAD00001010227	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0168_002 for Diffuse large B-cell lymphoma patient sample TFRIPAIR3_DLBCL	Illumina HiSeq 2500	1
EGAD00001010228	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0169_002 for Diffuse large B-cell lymphoma patient sample TFRIPAIR4_DLBCL	Illumina HiSeq 2500	1
EGAD00001010229	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0170_002A for Diffuse large B-cell lymphoma patient sample TFRIPAIR5_DLBCL	Illumina HiSeq 2500	1
EGAD00001010230	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0171_002A for Diffuse large B-cell lymphoma patient sample TFRI_Pair_6_DLBCL	Illumina HiSeq 2500	1
EGAD00001010231	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0178_002A for Diffuse large B-cell lymphoma patient sample TFRIPAIR8_DLBCL	Illumina HiSeq 2500	1
EGAD00001010232	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0183_002A for Diffuse large B-cell lymphoma patient sample TFRI_Pair_9_DLBCL	Illumina HiSeq 2500	1
EGAD00001010234	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0188_002A for Diffuse large B-cell lymphoma patient sample TFRIPAIR11_DLBCL	Illumina HiSeq 2500	1
EGAD00001010235	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0197_002A for Diffuse large B-cell lymphoma patient sample TFRIPAIR12_DLBCL_rel	Illumina HiSeq 2500	1
EGAD00001010236	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0198_002A for Diffuse large B-cell lymphoma patient sample TFRI_Pair_13_DLBCL	Illumina HiSeq 2500	1
EGAD00001010237	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0198_004A for Lymph node patient sample RLN_02_5Prime	Illumina HiSeq 2500	1
EGAD00001010238	10x Single Cell Gene Expression library SCRNA10X_CS_CHIP0198_005A for Lymph node patient sample RLN_03_5Prime	Illumina HiSeq 2500	1
EGAD00001010239	DLP+ Single Cell Genomic Library 98211 for Diffuse large B-cell lymphoma patient sample TFRIPAIR11_DLBCL	HiSeq X Ten	1
EGAD00001010240	DLP+ Single Cell Genomic Library A98180 for Diffuse large B-cell lymphoma patient sample TFRI_Pair_13_DLBCL	HiSeq X Ten	1
EGAD00001010241	DLP+ Single Cell Genomic Library A98193 for Follicular lymphoma patient sample TFRI_Pair_6_FL	HiSeq X Ten	1
EGAD00001010242	DLP+ Single Cell Genomic Library A98203 for Diffuse large B-cell lymphoma patient sample TFRIPAIR8_DLBCL	HiSeq X Ten	1
EGAD00001010243	DLP+ Single Cell Genomic Library A98205 for Follicular lymphoma patient sample TFRIPAIR9_FL	HiSeq X Ten	1
EGAD00001010244	DLP+ Single Cell Genomic Library A98208 for Diffuse large B-cell lymphoma patient sample TFRIPAIR10_DLBCL	HiSeq X Ten	1
EGAD00001010245	DLP+ Single Cell Genomic Library A98221A for Follicular lymphoma patient sample TFRIPAIR5_FL	HiSeq X Ten	1
EGAD00001010246	DLP+ Single Cell Genomic Library A98225 for Diffuse large B-cell lymphoma patient sample TFRIPAIR12_DLBCL_rel	HiSeq X Ten	1
EGAD00001010247	DLP+ Single Cell Genomic Library A98288 for Follicular lymphoma patient sample TFRIPAIR2_FL	HiSeq X Ten	1
EGAD00001010248	DLP+ Single Cell Genomic Library A98297 for Follicular lymphoma patient sample TFRIPAIR3_FL	HiSeq X Ten	1
EGAD00001010249	DLP+ Single Cell Genomic Library A98167 for Diffuse large B-cell lymphoma patient sample TFRIPAIR4_DLBCL	HiSeq X Ten	1
EGAD00001010327	Targeted capture ctDNA Library CRCQV34Run002-10 from patient PBC0002108, plasma baseline sample	Illumina MiSeq	1
EGAD00001010328	Targeted capture ctDNA Library CRCQV34Run002-11 from patient PBC0002429, plasma baseline sample	Illumina MiSeq	1
EGAD00001010329	Targeted capture ctDNA Library CRCQV34Run002-12 from patient PBC0002459, plasma baseline sample	Illumina MiSeq	1
EGAD00001010330	Targeted capture ctDNA Library CRCQV34Run002-13 from patient PBC0002595, plasma baseline sample	Illumina MiSeq	1
EGAD00001010331	Targeted capture ctDNA Library CRCQV34Run002-14 from patient PBC0001051, saliva sample	Illumina MiSeq	1
EGAD00001010332	Targeted capture ctDNA Library CRCQV34Run002-16 from patient PBC0001627, saliva sample	Illumina MiSeq	1
EGAD00001010333	Targeted capture ctDNA Library CRCQV34Run002-18 from patient PBC0002062, saliva sample	Illumina MiSeq	1
EGAD00001010334	Targeted capture ctDNA Library CRCQV34Run002-20 from patient PBC0002108, saliva sample	Illumina MiSeq	1
EGAD00001010335	Targeted capture ctDNA Library CRCQV34Run002-21 from patient PBC0002429, saliva sample	Illumina MiSeq	1
EGAD00001010336	Targeted capture ctDNA Library CRCQV34Run002-22 from patient PBC0002459, saliva sample	Illumina MiSeq	1
EGAD00001010337	Targeted capture ctDNA Library CRCQV34Run002-23 from patient PBC0002595, saliva sample	Illumina MiSeq	1
EGAD00001010338	Targeted capture ctDNA Library CRCQV34Run002-4 from patient PBC0001051, plasma baseline sample	Illumina MiSeq	1
EGAD00001010339	Targeted capture ctDNA Library CRCQV34Run002-6 from patient PBC0001627, plasma baseline sample	Illumina MiSeq	1
EGAD00001010340	Targeted capture ctDNA Library CRCQV34Run002-8 from patient PBC0002062, plasma baseline sample	Illumina MiSeq	1
EGAD00001010341	Targeted capture ctDNA Library CRCQV34Run005-10 from patient PBC0002459, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010342	Targeted capture ctDNA Library CRCQV34Run005-11 from patient PBC0002595, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010343	Targeted capture ctDNA Library CRCQV34Run005-12 from patient PBC0001224, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010344	Targeted capture ctDNA Library CRCQV34Run005-13 from patient PBC0002383, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010345	Targeted capture ctDNA Library CRCQV34Run005-14 from patient PBC0002816, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010346	Targeted capture ctDNA Library CRCQV34Run005-15 from patient PBC0002824, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010347	Targeted capture ctDNA Library CRCQV34Run005-18 from patient PBC0001845, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010348	Targeted capture ctDNA Library CRCQV34Run005-20 from patient PBC0002680, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010349	Targeted capture ctDNA Library CRCQV34Run005-4 from patient PBC0001627, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010350	Targeted capture ctDNA Library CRCQV34Run005-5 from patient PBC0002062, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010351	Targeted capture ctDNA Library CRCQV34Run005-8 from patient PBC0002108, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010352	Targeted capture ctDNA Library CRCQV34Run005-9 from patient PBC0002429, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010353	Targeted capture ctDNA Library CRCQV34Run007-10 from patient PBC0002680, plasma baseline sample	Illumina MiSeq	1
EGAD00001010354	Targeted capture ctDNA Library CRCQV34Run007-12 from patient PBC0002816, plasma baseline sample	Illumina MiSeq	1
EGAD00001010355	Targeted capture ctDNA Library CRCQV34Run007-13 from patient PBC0002824, plasma baseline sample	Illumina MiSeq	1
EGAD00001010356	Targeted capture ctDNA Library CRCQV34Run007-15 from patient PBC0001255, saliva sample	Illumina MiSeq	1
EGAD00001010357	Targeted capture ctDNA Library CRCQV34Run007-18 from patient PBC0001845, saliva sample	Illumina MiSeq	1
EGAD00001010358	Targeted capture ctDNA Library CRCQV34Run007-20 from patient PBC0002680, saliva sample	Illumina MiSeq	1
EGAD00001010359	Targeted capture ctDNA Library CRCQV34Run007-22 from patient PBC0002816, buffy coat sample	Illumina MiSeq	1
EGAD00001010360	Targeted capture ctDNA Library CRCQV34Run007-23 from patient PBC0002824, buffy coat sample	Illumina MiSeq	1
EGAD00001010361	Targeted capture ctDNA Library CRCQV34Run007-24 from patient PBC0001051, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010362	Targeted capture ctDNA Library CRCQV34Run007-5 from patient PBC0001255, plasma baseline sample	Illumina MiSeq	1
EGAD00001010363	Targeted capture ctDNA Library CRCQV34Run007-8 from patient PBC0001845, plasma baseline sample	Illumina MiSeq	1
EGAD00001010364	Targeted capture ctDNA Library CRCQV34Run011-10 from patient PBC0001673, plasma baseline sample	Illumina MiSeq	1
EGAD00001010365	Targeted capture ctDNA Library CRCQV34Run011-11 from patient PBC0002255, plasma baseline sample	Illumina MiSeq	1
EGAD00001010366	Targeted capture ctDNA Library CRCQV34Run011-12 from patient PBC0002294, plasma baseline sample	Illumina MiSeq	1
EGAD00001010367	Targeted capture ctDNA Library CRCQV34Run011-13 from patient PBC0001328, plasma baseline sample	Illumina MiSeq	1
EGAD00001010368	Targeted capture ctDNA Library CRCQV34Run011-14 from patient PBC0001224, saliva sample	Illumina MiSeq	1
EGAD00001010369	Targeted capture ctDNA Library CRCQV34Run011-15 from patient PBC0002383, buffy coat sample	Illumina MiSeq	1
EGAD00001010370	Targeted capture ctDNA Library CRCQV34Run011-18 from patient PBC0001432, saliva sample	Illumina MiSeq	1
EGAD00001010371	Targeted capture ctDNA Library CRCQV34Run011-20 from patient PBC0001673, saliva sample	Illumina MiSeq	1
EGAD00001010372	Targeted capture ctDNA Library CRCQV34Run011-21 from patient PBC0002255, saliva sample	Illumina MiSeq	1
EGAD00001010373	Targeted capture ctDNA Library CRCQV34Run011-22 from patient PBC0002294, saliva sample	Illumina MiSeq	1
EGAD00001010374	Targeted capture ctDNA Library CRCQV34Run011-23 from patient PBC0001328, saliva sample	Illumina MiSeq	1
EGAD00001010375	Targeted capture ctDNA Library CRCQV34Run011-4 from patient PBC0001224, plasma baseline sample	Illumina MiSeq	1
EGAD00001010376	Targeted capture ctDNA Library CRCQV34Run011-5 from patient PBC0002383, plasma baseline sample	Illumina MiSeq	1
EGAD00001010377	Targeted capture ctDNA Library CRCQV34Run011-8 from patient PBC0001432, plasma baseline sample	Illumina MiSeq	1
EGAD00001010378	Targeted capture ctDNA Library CRCQV34Run015-12 from patient PBC0002108, plasma 12 month sample	Illumina MiSeq	1
EGAD00001010379	Targeted capture ctDNA Library CRCQV34Run015-13 from patient PBC0002459, plasma 9 month sample	Illumina MiSeq	1
EGAD00001010380	Targeted capture ctDNA Library CRCQV34Run015-14 from patient PBC0002595, plasma 6 month sample	Illumina MiSeq	1
EGAD00001010381	Targeted capture ctDNA Library CRCQV34Run015-17 from patient PBC0002824, plasma 6 month sample	Illumina MiSeq	1
EGAD00001010382	Targeted capture ctDNA Library CRCQV34Run015-20 from patient PBC0001432, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010383	Targeted capture ctDNA Library CRCQV34Run015-22 from patient PBC0001673, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010384	Targeted capture ctDNA Library CRCQV34Run015-23 from patient PBC0001255, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010385	Targeted capture ctDNA Library CRCQV34Run015-24 from patient PBC0002255, TNBC FFPE sample	Illumina MiSeq	1
EGAD00001010386	Targeted capture ctDNA Library CRCQV34Run015-9 from patient PBC0001627, plasma 12 month sample	Illumina MiSeq	1
EGAD00001010387	Targeted capture ctDNA Library CRCQV40Run027-10 from patient PBC0004414, saliva sample	Illumina MiSeq	1
EGAD00001010388